Bacterial infectious disease
MONDO:0005113An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.
Also known as: Bacteria caused disease or disorder, Bacteria disease or disorder, Bacteria infectious disease, bacterial disease, bacterial disorder, bacterial infection, bacterial infectious disease, infection, bacterial
2073 clinical trials for this condition and its sub-types, 96 tagged with Bacterial infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Bacterial infectious disease
-
Primary bacterial infectious disease 0 trials · 590 incl. sub-types
37 sub-types
- Tuberculosis 216 trials · 298 incl. sub-types Sub-types →
- Syphilis 47 trials · 56 incl. sub-types Sub-types →
- Gonorrhea 49 trials Sub-types →
- Tetanus 43 trials Sub-types →
- Lyme disease 30 trials
- Diphtheria 27 trials Sub-types →
- Mycobacterium avium complex disease 22 trials
- Anthrax infection 17 trials · 20 incl. sub-types Sub-types →
- Salmonellosis 5 trials · 19 incl. sub-types Sub-types →
- Cholera 16 trials
- Shigellosis 14 trials
- Leprosy 11 trials · 12 incl. sub-types Sub-types →
- Leptospirosis 9 trials Sub-types →
- Botulism 5 trials Sub-types →
- Listeriosis 4 trials Sub-types →
- Plague 2 trials · 4 incl. sub-types Sub-types →
- Buruli ulcer disease 3 trials
- Q fever 3 trials
- Campylobacteriosis 3 trials Sub-types →
- Melioidosis 3 trials
- Brucellosis 2 trials Sub-types →
- Legionellosis 1 trial · 2 incl. sub-types Sub-types →
- Relapsing fever 2 trials Sub-types →
- Bartonellosis 0 trials · 1 incl. sub-types Sub-types →
- Ehrlichiosis 1 trial Sub-types →
- Granuloma inguinale 0 trials · 1 incl. sub-types Sub-types →
- Ornithosis 1 trial
- Pinta disease 1 trial
- Borrelia miyamotoi disease 0 trials
- Chancroid 0 trials
- Glanders 0 trials
- Rhinoscleroma 0 trials
- Sennetsu fever 0 trials
- Spirillary rat-bite fever 0 trials
- Staphyloenterotoxemia 0 trials
- Streptobacillary rat-bite fever 0 trials
- Tularemia 0 trials Sub-types →
-
Mycobacterial infectious disease 23 trials · 360 incl. sub-types
7 sub-types
- Tuberculosis 216 trials · 298 incl. sub-types Sub-types →
- Pulmonary non-tuberculous mycobacterial infection 48 trials
- Mycobacterium avium complex disease 22 trials
- Leprosy 11 trials · 12 incl. sub-types Sub-types →
- Buruli ulcer disease 3 trials
- Mycobacterium xenopi infection 2 trials
- Aquarium granuloma 0 trials
-
Gram-negative bacterial infections 33 trials · 300 incl. sub-types
15 sub-types
- Helicobacter pylori infectious disease 115 trials
- Treponema infectious disease 6 trials · 57 incl. sub-types Sub-types →
- Chlamydiaceae infections 1 trial · 55 incl. sub-types Sub-types →
- Bordetellosis 0 trials · 39 incl. sub-types Sub-types →
- Moraxellaceae infectious disease 0 trials · 8 incl. sub-types Sub-types →
- Pneumonia caused by gram negative bacteria 5 trials · 7 incl. sub-types Sub-types →
- Rickettsiaceae infectious disease 0 trials · 4 incl. sub-types Sub-types →
- Burkholderia infectious disease 0 trials · 3 incl. sub-types Sub-types →
- Anaplasmataceae infectious disease 0 trials · 2 incl. sub-types Sub-types →
- Bartonellaceae infectious disease 0 trials · 1 incl. sub-types Sub-types →
- Bacteroidaceae infectious disease 0 trials Sub-types →
- Desulfovibrionaceae infectious disease 0 trials
- Fusobacteriaceae infectious disease 0 trials Sub-types →
- Bacterial meningitis caused by gram-negative bacteria 0 trials Sub-types →
- Streptobacillus infectious disease 0 trials Sub-types →
-
Commensal bacterial infectious disease 0 trials · 272 incl. sub-types
6 sub-types
- Toxic shock syndrome 224 trials Sub-types →
- Chlamydia trachomatis infectious disease 37 trials · 48 incl. sub-types Sub-types →
- Lemierre syndrome 0 trials
- Actinomycosis 0 trials Sub-types →
- Gas gangrene 0 trials
- Staphylococcal scalded skin syndrome 0 trials
-
Gram-positive bacterial infections 7 trials · 251 incl. sub-types
6 sub-types
- Streptococcal infection 19 trials · 131 incl. sub-types Sub-types →
- Clostridium infectious disease 48 trials · 96 incl. sub-types Sub-types →
- Bacillaceae infectious disease 1 trial · 20 incl. sub-types Sub-types →
- Actinomycetales infectious disease 1 trial Sub-types →
- Erysipelothrix infectious disease 0 trials Sub-types →
- Infection caused by Bifidobacterium 0 trials
-
Pulpitis 191 trials
-
Bacterial infectious disease with sepsis 78 trials · 113 incl. sub-types
5 sub-types
- Neonatal sepsis 35 trials
- Lemierre syndrome 0 trials
- Pasteurella hemorrhagic septicemia 0 trials
- Gas gangrene 0 trials
- Meningococcemia 0 trials
-
Bacterial sexually transmitted disease 8 trials · 113 incl. sub-types
5 sub-types
- Treponema infectious disease 6 trials · 57 incl. sub-types Sub-types →
- Chlamydia infectious disease 34 trials · 55 incl. sub-types Sub-types →
- Gonorrhea 49 trials Sub-types →
- Granuloma inguinale 0 trials · 1 incl. sub-types Sub-types →
- Chancroid 0 trials
-
Anaerobic bacteria infectious disease 2 trials · 99 incl. sub-types
10 sub-types
- Clostridium infectious disease 48 trials · 96 incl. sub-types Sub-types →
- Actinomycetales infectious disease 1 trial Sub-types →
- Bacteroides infectious disease 0 trials
- Fusobacterium infectious disease 0 trials
- Peptostreptococcus infectious disease 0 trials
- Anaerobic balanitis 0 trials
- Anaerobic cellulitis 0 trials
- Anaerobic meningitis 0 trials
- Anaerobic pneumonia 0 trials
- Infection caused by Bifidobacterium 0 trials
-
Spirochaetales infections 1 trial · 97 incl. sub-types
4 sub-types
- Treponema infectious disease 6 trials · 57 incl. sub-types Sub-types →
- Lyme disease 30 trials
- Leptospirosis 9 trials Sub-types →
- Borrelia infectious disease 6 trials · 7 incl. sub-types Sub-types →
-
Bacterial arthritis 24 trials · 94 incl. sub-types
6 sub-types
- Periprosthetic joint infection 76 trials
- Escherichia coli discitis 0 trials
- Gonococcal infection of joint 0 trials Sub-types →
- Salmonella discitis 0 trials
- Staphylococcus discitis 0 trials
- Streptococcus pneumoniae discitis 0 trials
-
Staphylococcal infection 41 trials · 84 incl. sub-types
4 sub-types
- Staphylococcus aureus infection 37 trials · 69 incl. sub-types Sub-types →
- Staphylococcal pneumonia 1 trial Sub-types →
- Staphylococcal toxemia 0 trials · 1 incl. sub-types Sub-types →
- Staphyloenterotoxemia 0 trials
-
Bacterial urinary tract infection 55 trials · 81 incl. sub-types
8 sub-types
- Pyelonephritis 8 trials · 21 incl. sub-types Sub-types →
- Acute cystitis 7 trials Sub-types →
- Urethritis 5 trials · 6 incl. sub-types Sub-types →
- Gonococcal cystitis 0 trials Sub-types →
- Neonatal urinary tract infectious disease 0 trials
- Renal tuberculosis 0 trials
- Ureter tuberculosis 0 trials
- Urinary bladder tuberculosis 0 trials
-
Clostridium difficile colitis 69 trials
-
Bacterial pneumonia 28 trials · 65 incl. sub-types
8 sub-types
- Streptococcal pneumonia 16 trials
- Mycoplasma pneumoniae pneumonia 9 trials
- Klebsiella pneumonia 7 trials
- Pneumonia caused by gram negative bacteria 5 trials · 7 incl. sub-types Sub-types →
- Pneumonia caused by pseudomonas aeruginosa infection 3 trials
- Legionnaires' disease 2 trials
- Staphylococcal pneumonia 1 trial Sub-types →
- Anaerobic pneumonia 0 trials
-
Skin disease caused by bacterial infection 13 trials · 57 incl. sub-types
17 sub-types
- Cellulitis 29 trials · 31 incl. sub-types Sub-types →
- Hordeolum 1 trial · 7 incl. sub-types Sub-types →
- Impetigo 5 trials Sub-types →
- Cutaneous anthrax 2 trials
- Erysipelas 1 trial
- Pinta disease 1 trial
- Aquarium granuloma 0 trials
- Bacillary angiomatosis 0 trials
- Bacterial exanthem 0 trials
- Bullous impetigo 0 trials
- Cutaneous diphtheria 0 trials
- Cutaneous syphilis 0 trials Sub-types →
- Cutaneous tuberculosis 0 trials Sub-types →
- Gas gangrene 0 trials
- Gonococcal keratitis 0 trials
- Staphylococcal scalded skin syndrome 0 trials
- Sycosis barbae 0 trials
-
Meningococcal infection 47 trials · 55 incl. sub-types
2 sub-types
- Meningococcal meningitis 18 trials
- Meningococcemia 0 trials
-
Bifidobacteriales infectious disease 0 trials · 44 incl. sub-types
2 sub-types
- Bacterial vaginosis 44 trials
- Infection caused by Bifidobacterium 0 trials
-
Bacterial meningitis 12 trials · 37 incl. sub-types
8 sub-types
- Meningococcal meningitis 18 trials
- Meningeal tuberculosis 7 trials
- Haemophilus meningitis 1 trial
- Escherichia coli meningitis 0 trials
- Listeria meningitis 0 trials
- Anaerobic meningitis 0 trials
- Bacterial meningitis caused by gram-negative bacteria 0 trials Sub-types →
- Streptococcal meningitis 0 trials Sub-types →
-
Pseudomonas infection 25 trials · 29 incl. sub-types
1 sub-type
-
Escherichia coli infection 26 trials
1 sub-type
- Escherichia coli discitis 0 trials
-
Vibrio infectious disease 0 trials · 16 incl. sub-types
2 sub-types
- Cholera 16 trials
- Vibrio vulnificus infectious disease 0 trials
-
Bacterial endocarditis 15 trials
-
Mycoplasmoides infection 7 trials · 15 incl. sub-types
2 sub-types
- Mycoplasma pneumoniae pneumonia 9 trials
- Mycoplasma encephalitis 0 trials
-
Haemophilus infectious disease 14 trials
2 sub-types
- Haemophilus meningitis 1 trial
- Chancroid 0 trials
-
Necrotizing soft tissue infection 13 trials
2 sub-types
- Necrotizing cellulitis 0 trials
- Necrotizing myositis 0 trials
-
Empyema 10 trials · 11 incl. sub-types
2 sub-types
- Subdural empyema 1 trial
- Tuberculous empyema 0 trials
-
Chorioamnionitis 10 trials
-
Klebsiella infectious disease 5 trials · 9 incl. sub-types
3 sub-types
- Klebsiella pneumonia 7 trials
- Granuloma inguinale 0 trials · 1 incl. sub-types Sub-types →
- Rhinoscleroma 0 trials
-
Rickettsiosis 2 trials · 7 incl. sub-types
3 sub-types
- Rickettsiaceae infectious disease 0 trials · 4 incl. sub-types Sub-types →
- Anaplasmataceae infectious disease 0 trials · 2 incl. sub-types Sub-types →
- Tick-borne relapsing fever 0 trials
-
Tracheitis 2 trials · 7 incl. sub-types
1 sub-type
- Laryngotracheitis 1 trial · 5 incl. sub-types Sub-types →
-
Peritonsillar abscess 4 trials
-
Enterococcus infectious disease 1 trial · 4 incl. sub-types
1 sub-type
- Enterococcus faecalis infection 3 trials
-
Yersinia infectious disease 0 trials · 4 incl. sub-types
3 sub-types
- Plague 2 trials · 4 incl. sub-types Sub-types →
- Yersinia enterocolitica infectious disease 0 trials
- Yersinia pseudotuberculosis infectious disease 0 trials Sub-types →
-
Bacterial conjunctivitis 3 trials
3 sub-types
- Gonococcal conjunctivitis 0 trials Sub-types →
- Inclusion conjunctivitis 0 trials
- Pseudomembranous conjunctivitis 0 trials Sub-types →
-
Bacterial hemorrhagic fever 0 trials · 3 incl. sub-types
1 sub-type
- Scrub typhus 3 trials
-
Bacterial gastritis 2 trials
-
Fournier gangrene 2 trials
-
Septic peritonitis 2 trials
-
Opportunistic bacterial infectious disease 0 trials · 1 incl. sub-types
2 sub-types
- Nocardiosis 1 trial
- Cepacia syndrome 0 trials
-
Actinobacillus infectious disease 0 trials
-
1 sub-type
-
Pectobacterium carotovorum infection 0 trials
-
Proteus infectious disease 0 trials
-
Whipple disease 0 trials
-
Bacterial myositis 0 trials
1 sub-type
- Pyomyositis 0 trials
-
Botryomycosis 0 trials
2 sub-types
- Cutaneous botryomycosis 0 trials
- Visceral botryomycosis 0 trials
-
Idiopathic severe pneumococcemia 0 trials
-
Noma 0 trials
-
Pasteurellosis 0 trials
1 sub-type
-
Pneumonic pasteurellosis 0 trials
-
Rat-bite fever 0 trials
2 sub-types
- Spirillary rat-bite fever 0 trials
- Streptobacillary rat-bite fever 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 724 trials in this tab.
-
New antibiotic goes Head-to-Head with old guard in fight against tough skin infections
Cure CompletedResearchers are comparing ceftobiprole, an intravenous antibiotic, with a standard combination of vancomycin plus aztreonam for treating acute bacterial skin and skin structure infections in hospitalized adults. The trial enrolls adults with serious skin infections such as cellul…
Phase 3 • Sponsor: Basilea Pharmaceutica • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Can a 4-Month drug cocktail cure TB as well as 6 months?
Cure CompletedResearchers in India are studying whether a 4-month daily regimen that includes moxifloxacin can cure newly diagnosed, microbiologically confirmed pulmonary tuberculosis as effectively as the standard 6-month treatment. The study enrolls 550 adults aged 18 to 65 who have not yet …
Sponsor: Tuberculosis Research Centre, India • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Antibiotic showdown: can tigecycline match older drugs against tough skin infections?
Cure CompletedThis trial compares the antibiotic tigecycline with two older antibiotics, ampicillin-sulbactam and amoxicillin-clavulanate, in adults with complicated skin or skin structure infections that need intravenous treatment. About 550 participants receive one of the treatments for 4 to…
Phase 4 • Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
Two antibiotic cocktails face off to wipe out stomach bacteria
Cure CompletedResearchers compare two 14-day oral antibiotic regimens for eradicating Helicobacter pylori, the bacterium behind most stomach ulcers. One regimen combines bismuth, doxycycline, metronidazole, and esomeprazole; the other adds bismuth to clarithromycin, amoxicillin, and esomeprazo…
Phase 3 • Sponsor: Reham Abdelkader Elkhouly • Aim: Cure
Last updated Sep 13, 2026 00:00 UTC
-
9-Month TB cure trial shows promise for Drug-Resistant patients
Cure CompletedThis study tested a 9-month treatment plan for people with multidrug-resistant tuberculosis (MDR-TB) in Gabon. The goal was to see if this shorter regimen could cure the disease with fewer side effects. 23 patients aged 15 and older took part, and the study tracked how many were …
Sponsor: Centre de Recherche Médicale de Lambaréné • Aim: Cure
Last updated Jun 27, 2026 11:03 UTC
-
Could a simple pill replace the shot for syphilis?
Cure CompletedThis study tested whether a 14-day course of doxycycline pills works as well as the standard penicillin shot for curing early syphilis. About 200 adults with early-stage syphilis took part. The goal is to offer a reliable oral option, especially when penicillin is in short supply…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Cure
Last updated Jun 27, 2026 07:58 UTC
-
Promising lyme vaccine moves to next stage in human trials
Vaccine CompletedThis study tested a new vaccine called VLA15 to prevent Lyme disease, which is spread by tick bites. Researchers gave the vaccine or a placebo to 625 healthy people aged 5 to 65. The goal was to check safety and how well the vaccine triggers an immune response. Results showed the…
Phase 2 • Sponsor: Pfizer • Aim: Vaccine
Last updated Sep 17, 2026 00:00 UTC
-
Can one shot replace six? a new vaccine aims to protect infants from six diseases at once
Vaccine CompletedResearchers are testing a new vaccine called LBVD that combines protection against diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib into a single injection. The study will enroll healthy infants aged 6 to 8 weeks, who will receive three doses at 6, 10, and 14 week…
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
New vaccine aims to protect african children from deadly salmonella
Vaccine CompletedThis study tests a new vaccine (iNTS-GMMA) designed to prevent severe Salmonella infections caused by two common strains. Researchers are giving the vaccine to healthy adults, children, and infants in Ghana to check if it is safe and triggers a strong immune response. The ultimat…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Sep 04, 2026 00:00 UTC
-
Can a Five-Part vaccine bolster protection against three serious infections?
Vaccine CompletedThis trial evaluates a new five-component vaccine (Tdcp) designed to protect against diphtheria, tetanus, and pertussis (whooping cough). It includes about 1,820 participants aged 7 and older, who receive either the experimental vaccine or a control vaccine. The study measures ho…
Phase 2/3 • Sponsor: CanSino Biologics Inc. • Aim: Vaccine
Last updated Aug 28, 2026 00:00 UTC
-
Can a peptide vaccine outsmart pneumonia?
Vaccine CompletedThis early-stage trial is testing a new vaccine called V-212, designed to protect against pneumococcal disease caused by the bacterium Streptococcus pneumoniae. The study involves 60 healthy adults aged 18-45 who will receive either the vaccine or a placebo in three doses. Resear…
Early phase 1 • Sponsor: Virometix • Aim: Vaccine
Last updated Aug 22, 2026 00:00 UTC
-
Can a drinkable vaccine stop Shigella's grip?
Vaccine CompletedThis trial tests an experimental oral vaccine, WRSs2, designed to protect against Shigella sonnei, a common cause of severe diarrhea. Healthy adults aged 18-49 receive either the vaccine or a placebo, then are later exposed to the live bacteria in a controlled setting to see if t…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Aug 12, 2026 00:00 UTC
-
New shigella vaccine shows promise for infants in phase 2 trial
Vaccine CompletedThis study tested a new vaccine called Shigella4V2 to protect infants against shigellosis, a severe diarrheal disease. Researchers gave the vaccine to 110 healthy 9-month-old babies to check its safety and how well it triggers an immune response. The goal is to find the best dose…
Phase 2 • Sponsor: LimmaTech Biologics AG • Aim: Vaccine
Last updated Aug 09, 2026 00:00 UTC
-
Can a new tetanus shot offer stronger protection?
Vaccine CompletedThis trial is testing a new tetanus vaccine in healthy adults aged 18 to 43. The goal is to see if the vaccine is safe and triggers a strong immune response, measured by antibody levels one month after vaccination. Participants will receive either the new vaccine or a control vac…
Phase 3 • Sponsor: Beijing Minhai Biotechnology Co., Ltd • Aim: Vaccine
Last updated Aug 05, 2026 00:00 UTC
-
New staph vaccine shows promise in early human trial
Vaccine CompletedThis early-stage study tested a new vaccine called LTB-SA7 designed to protect against infections caused by Staphylococcus aureus bacteria. 129 healthy adults received either the vaccine or a placebo to check for safety and to see if the vaccine triggers an immune response. The s…
Phase 1 • Sponsor: LimmaTech Biologics AG • Aim: Vaccine
Last updated Aug 05, 2026 00:00 UTC
-
Rebooting immunity: can vaccines shield childhood cancer survivors from preventable diseases?
Vaccine CompletedThis trial investigates how well routine childhood vaccines work in children who have recently finished chemotherapy for cancer. The goal is to see if revaccination can restore protective immunity against diseases like measles, mumps, and whooping cough. Participants receive a se…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Vaccine
Last updated Jul 31, 2026 00:00 UTC
-
Broader pneumonia shield: new vaccine tested in children
Vaccine CompletedThis study tests a 13-valent pneumococcal conjugate vaccine in healthy children aged 15 months to 17 years. The goal is to see if the vaccine is safe and triggers a strong immune response against 13 types of pneumococcal bacteria. Participants receive one or two doses, and resear…
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jul 23, 2026 00:00 UTC
-
Could a vaccine shield newborns from a deadly bacterial infection?
Vaccine CompletedThis study tests an experimental vaccine called GBS-NN/NN2 against Group B Streptococcus (GBS), a bacteria that can cause serious infections in newborns. The trial includes pregnant women both with and without HIV, giving two doses between 26 and 30 weeks of pregnancy. Researcher…
Phase 2 • Sponsor: Minervax ApS • Aim: Vaccine
Last updated Jul 16, 2026 00:00 UTC
-
Could a Lower-Dose polio vaccine help eradicate the disease?
Vaccine CompletedThis study tests a hexavalent vaccine that protects against six diseases, including polio, but uses a lower dose of the inactivated polio vaccine (IPV). The goal is to see if this reduced-dose version works as well as the standard full-dose vaccine in infants. Around 1,500 health…
Phase 3 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Vaccine
Last updated Jul 03, 2026 00:00 UTC
-
One shot to rule them all? new vaccine targets five meningococcal strains in infants
Vaccine CompletedThis study tested a new combination vaccine designed to protect healthy infants against five types of meningococcal bacteria (A, B, C, W, and Y) that can cause serious infections like meningitis. Over 700 infants received different doses or combinations of the vaccine to check sa…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 28, 2026 00:00 UTC
-
New vaccine aims to protect infants from deadly diarrhea
Vaccine CompletedThis study tests a new vaccine called Shigella4V, designed to protect against shigellosis, a severe diarrheal disease. Researchers are giving the vaccine to healthy adults, children, and 9-month-old infants to check its safety and whether it triggers a strong immune response. Dif…
Phase 1/2 • Sponsor: LimmaTech Biologics AG • Aim: Vaccine
Last updated Jun 27, 2026 14:03 UTC
-
Meningitis b vaccine shows promise in children
Vaccine CompletedThis study looked at how well the MenBVac vaccine protects children against a specific type of meningitis B bacteria. Researchers measured the immune response in 218 children who had already received five doses of the vaccine. The goal was to see if the children had enough antibo…
Phase 4 • Sponsor: University Hospital, Rouen • Aim: Vaccine
Last updated Jun 27, 2026 13:08 UTC
-
Meningitis b vaccine booster shows promise in kids
Vaccine CompletedThis study tested whether a fourth dose of the MenBVac vaccine boosts protection against meningitis B in children. Researchers measured immune responses in 120 children before and after the booster. The goal was to see if the vaccine maintains protective antibody levels over time…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Vaccine
Last updated Jun 27, 2026 13:07 UTC
-
Major lyme vaccine trial shows promise in thousands
Vaccine CompletedThis study tested a new vaccine (VLA15) to prevent Lyme disease, a tick-borne illness. About 12,500 healthy people aged 5 and older in high-risk areas received either the vaccine or a placebo. The goal was to see if the vaccine safely reduces Lyme disease cases compared to no vac…
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 13:02 UTC
-
Does the meningitis b vaccine last? study tests kids 4 years later
Vaccine CompletedThis study looked at 117 children aged 4-8 who had received four doses of the MenBVac vaccine against meningitis B. Researchers measured how many still had protective antibodies four years after the last dose. The goal was to see if the vaccine's immunity lasts over time.
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
Massive typhoid vaccine trial aims to curb fever in india
Vaccine CompletedThis large study tested a typhoid conjugate vaccine called TyphiBEV in over 72,000 people aged 1 to 30 years in Vellore, India. The goal was to see if the vaccine reduces the number of confirmed typhoid fever cases in vaccinated communities compared to unvaccinated ones. The tria…
Phase 4 • Sponsor: Christian Medical College, Vellore, India • Aim: Vaccine
Last updated Jun 27, 2026 11:02 UTC
-
New vaccine V116 aims to shield vulnerable kids from pneumococcal disease
Vaccine CompletedThis study tested a new vaccine called V116 in 882 children and teenagers aged 2 to 17 who have a higher risk of pneumococcal disease due to conditions like diabetes or chronic lung disease. The goal was to see if V116 is as good as or better than the current vaccine PPSV23 at tr…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Vaccine
Last updated Jun 27, 2026 11:00 UTC
-
Thousands monitored: is the whooping cough vaccine safe in real life?
Vaccine CompletedThis completed study tracked over 10,000 people in Thailand who received the Boostagen® vaccine, which protects against tetanus, diphtheria, and whooping cough. Healthcare workers reported any side effects to see how safe the vaccine is in everyday use. The study also looked at p…
Sponsor: BioNet-Asia Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 09:09 UTC
-
New vaccine aims to shield High-Risk adults from pneumococcal disease
Vaccine CompletedThis completed Phase 3 study tested a new vaccine called V116 in 518 adults aged 18 to 64 who are at increased risk for pneumococcal disease due to conditions like diabetes or chronic lung disease. The vaccine targets 21 strains of the bacteria that cause pneumonia and other infe…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Vaccine
Last updated Jun 27, 2026 09:09 UTC
-
New vaccine strategy aims to shield spleenless adults from deadly infections
Vaccine CompletedThis study tested a two-step vaccine approach in 70 adults who had their spleen removed. Participants received one shot of a conjugate vaccine followed by a second shot of a polysaccharide vaccine two months later. The goal was to see if this combination triggers a strong immune …
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Vaccine
Last updated Jun 27, 2026 07:58 UTC
-
New pneumonia vaccine passes first safety check in small human trial
Vaccine CompletedThis early-stage trial tested whether a new whole-cell pneumonia vaccine is safe for people. Thirty healthy adults received either the vaccine or a placebo and were monitored for 30 days. The main goal was to check for side effects like pain, fever, or headache. This study does n…
Phase 1 • Sponsor: Serum Life Science Europe GmbH • Aim: Vaccine
Last updated Jun 27, 2026 07:55 UTC
-
Can a Once-Daily HIV pill with food match Twice-Daily dosing during TB treatment?
Disease control CompletedResearchers are testing two ways to give the HIV drug dolutegravir to people who also have tuberculosis and are taking rifampin-based TB therapy. Rifampin can lower dolutegravir levels in the body, so the trial compares taking 50 mg once daily with food against taking 50 mg twice…
Phase 2 • Sponsor: The HIV Netherlands Australia Thailand Research Collaboration • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Poop pills could stop recurrent UTIs without antibiotics
Disease control CompletedThis completed Phase 2 trial tested fecal microbiota transfer (FMT) – a freeze-dried product made from healthy donor stool – in 40 women with recurrent urinary tract infections (UTIs). The goal was to see if FMT could prevent future UTIs by restoring healthy gut bacteria. Researc…
Phase 2 • Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a probiotic shield kids from antibiotic side effects?
Disease control CompletedThis study tests whether giving a probiotic (Saccharomyces boulardii) along with a common antibiotic can protect the gut bacteria of children aged 4 to 12 being treated for ear or sinus infections. The goal is to see if it reduces antibiotic-associated diarrhea and limits the spr…
Phase 4 • Sponsor: Eskisehir Osmangazi University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Dietary change may curb recurrent c. diff in cancer patients
Disease control CompletedThis study tested whether eating less fat and more fiber can reduce the chance of a repeat Clostridioides difficile infection in cancer patients. Eight participants with leukemia, lymphoma, or other cancers followed a specific diet. Researchers tracked diarrhea and measured C. di…
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New booster vaccine trial aims to shield japanese teens from three serious diseases
Disease control CompletedThis study tests a single booster dose of a combined vaccine against diphtheria, tetanus, and whooping cough (dTpa) in 85 healthy Japanese adolescents aged 11 to 13. Researchers will check if the shot triggers a strong immune response and monitor for side effects one month after …
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can starting TB treatment immediately save lives in HIV sepsis?
Disease control CompletedIn sub-Saharan Africa, tuberculosis often causes sepsis in people living with HIV, and many die within days. This phase 3 trial tests two changes to standard care: starting anti-TB therapy right away instead of waiting for test results, and using a higher, sepsis-specific dose in…
Phase 3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Nanobody drug tested against painful skin condition
Disease control CompletedResearchers are testing a drug called sonelokimab in adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps and abscesses. The trial compares sonelokimab, given by injection, with a placebo and with adalimumab, an existing trea…
Phase 2 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a common arthritis drug tame the painful Flare-Ups of leprosy?
Disease control CompletedThis trial tests whether adding methotrexate to the standard steroid prednisolone better controls erythema nodosum leprosum (ENL), a painful and often recurring complication of leprosy. Adults aged 18 to 65 with active ENL will receive either prednisolone alone or prednisolone pl…
Phase 1 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New dental cements could save painful teeth from root canals
Disease control CompletedThis study tests two calcium silicate-based dental cements, Biodentine and NeoPutty, for treating irreversible pulpitis (severe tooth nerve inflammation) in adults. Sixty participants with deep cavities and spontaneous pain will receive a single-session pulpotomy, where the infla…
Phase 4 • Sponsor: Firat University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New bacteria slurry takes on poop transplants for stubborn gut infection
Disease control CompletedThis study tests two treatments for people with repeat C. diff infections: a lab-made bacteria mix called MTC01 and a fecal transplant (FMT) from a healthy donor. Both are given during a colonoscopy. The goal is to see which is safer and better at stopping the infection from comi…
Phase 1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Poop pills could protect gut after colon surgery – early trial begins
Disease control CompletedThis early-stage trial is testing whether a pill made from freeze-dried healthy donor stool (MTP-101P) is safe and can restore good bacteria in people having part of their colon removed. Forty adults aged 18-75 with colon polyps, early-stage cancer, or diverticulitis will take th…
Phase 1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a heart drug save lives in septic shock? new trial aims to find out.
Disease control CompletedThis study tests a drug called ivabradine in 429 adults with septic shock, a life-threatening condition where infection causes dangerously low blood pressure. Many patients develop a fast heart rate, which can worsen outcomes. Ivabradine slows the heart without weakening its pump…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a pill replace an IV for Drug-Resistant shigella in children?
Disease control CompletedThis trial tests whether an oral antibiotic called tebipenem-pivoxil works as well as the standard IV antibiotic ceftriaxone for children with shigellosis, a severe diarrheal disease, when first-line treatment fails. The study enrolls children aged 24 to 59 months who have not im…
Phase 2 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a higher dose of rifampicin clear TB around the heart faster?
Disease control CompletedThis trial tests whether giving a higher dose of the antibiotic rifampicin (35 mg/kg) can increase drug levels in the fluid around the heart and clear tuberculosis bacteria faster than the standard dose (10 mg/kg). The study enrolls adults with suspected tuberculous pericarditis,…
Phase 2 • Sponsor: University of Cape Town • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a new pill shorten tuberculosis treatment?
Disease control CompletedThis trial tests an experimental antibiotic called BTZ-043 in adults with newly diagnosed, drug-sensitive pulmonary tuberculosis. Participants take the drug by mouth once daily for 14 days, and researchers compare it to a standard combination treatment. The main goal is to check …
Phase 1/2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a second drug boost the cure rate for a common sexually transmitted infection?
Disease control CompletedThis trial tests whether adding tinidazole to the standard antibiotics doxycycline or azithromycin cures non-gonococcal urethritis (NGU) better than antibiotics alone. NGU is a bacterial infection causing inflammation of the urethra, often passed through sex. About 300 men aged 1…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a 4-Drug combo cut TB treatment time in half?
Disease control CompletedThis trial tests a new combination of four drugs, called BPaMZ, for treating tuberculosis. People with drug-sensitive TB receive BPaMZ for 4 months, compared to the standard 6-month regimen. People with drug-resistant TB receive BPaMZ for 6 months. The study measures how well the…
Phase 2/3 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a muffin help heal stomach ulcers?
Disease control CompletedResearchers are testing whether muffins enriched with pomegranate peel powder can help people with stomach ulcers caused by H. pylori infection. The trial gives participants either a regular whole wheat muffin or one with 1.5 or 3 grams of pomegranate peel powder, alongside their…
Sponsor: University of Lahore • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could two common vitamins tame the chaos of sepsis?
Disease control CompletedThis trial tests whether giving thiamine (vitamin B1), vitamin C, or both, alongside standard care, can reduce harmful inflammation and tissue damage in adults with sepsis. The study will measure blood markers of inflammation and tissue remodeling before and after 72 hours of tre…
Sponsor: Universitas Sumatera Utara • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could eggshells fix Kids' cavities? new trial tests natural pulp treatment
Disease control CompletedThis study compares eggshell powder to Biodentine for treating tooth pulp exposure in children's baby molars. Thirty kids with deep cavities but no infection will get a pulpotomy, where the damaged pulp is removed and the material is placed. Researchers will check for pain, swell…
Sponsor: Tanta University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Ambulance sepsis blitz: early treatment cuts deaths?
Disease control CompletedThis study tested whether giving strong, early treatment to people with severe sepsis or septic shock right in the ambulance could lower the number of deaths. The treatment included early antibiotics and fluids to support blood pressure. The study involved 398 adults and measured…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a simple cup cut STIs and BV? new trial hopes so
Disease control CompletedThis study tests whether giving menstrual cups to economically vulnerable women in Kenya can lower rates of bacterial vaginosis (BV) and sexually transmitted infections (STIs). The cup is a reusable silicone device that collects menstrual blood and can be worn during sex. Researc…
Phase 2 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can an antidepressant stabilize blood pressure in septic shock?
Disease control CompletedThis phase 2 trial investigates whether paroxetine, a common antidepressant, can improve cardiovascular function in patients with septic shock. Septic shock causes dangerously low blood pressure and poor response to standard vasopressor drugs. The study will give paroxetine or a …
Phase 2 • Sponsor: Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a new filling material save baby teeth when adult teeth are missing?
Disease control CompletedThis trial explores whether a bioceramic sealer, used alone, can effectively fill root canals in baby molars when the permanent successor is missing. Thirty healthy children with deep decay in a lower second baby molar will receive the treatment and be followed for up to two year…
Phase 4 • Sponsor: Osama Seif El-Nasr Hussein Gad El-Hak • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New antibiotic vabomere tested in kids for first time
Disease control CompletedThis study is testing a single dose of the antibiotic Vabomere in 39 children from birth to under 18 years old who have serious bacterial infections. The goal is to find the right dose and check how safe and tolerable the drug is. All children are hospitalized and receiving other…
Phase 1 • Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a higher steroid dose help preterm babies breathe easier?
Disease control CompletedThis study looks at whether a higher dose of dexamethasone, a steroid given to pregnant women at risk of early birth, helps preterm babies' lungs mature better. Researchers are comparing babies born between 26 and 36 weeks whose mothers received either 12 mg or 6 mg of dexamethas…
Sponsor: Stella Maris Women and Children Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a more powerful antibiotic clear TB faster? a trial puts rifapentine to the test.
Disease control CompletedThis trial compares the antibiotic rifapentine against the standard drug rifampin during the first 8 weeks of treatment for pulmonary tuberculosis. About 334 adults with TB bacteria in their sputum are randomly assigned to receive either the standard regimen or one with rifapenti…
Phase 2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Friendly bacteria vs. vaginal infections: a new trial puts probiotics to the test
Disease control CompletedThis virtual trial tests whether a daily prebiotic and probiotic supplement can relieve symptoms of bacterial vaginosis and yeast infections, such as itching, odor, and abnormal discharge. Women aged 25 and older with these concerns will take two capsules daily for 30 days. The s…
Sponsor: Happy V • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Bee glue vs. toothache: could propolis replace standard pulpotomy care?
Disease control CompletedThis trial tests whether propolis, a natural resin from bees, can control bleeding during a tooth-saving procedure called full pulpotomy for adults with painful, inflamed molars. Participants are randomly assigned to receive propolis or the standard sodium hypochlorite as a hemos…
Sponsor: Misr International University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a simple pill replace IV drips for blood infections?
Disease control CompletedThis study tests whether stable patients with a common blood infection (gram-negative bacteraemia) can safely switch from IV antibiotics to oral pills within 72 hours. Researchers will compare early oral therapy to continued IV treatment in 720 adults. The main goal is to see if …
Phase 4 • Sponsor: Tan Tock Seng Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a common diabetes drug help fight TB in HIV patients?
Disease control CompletedThis study looked at whether adding metformin, a diabetes drug, to standard tuberculosis (TB) treatment is safe and tolerable for people also living with HIV. 112 adults with TB and HIV took either standard TB medicines alone or with metformin for 11 weeks. Researchers monitored …
Phase 2 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a shorter TB regimen transform child care?
Disease control CompletedThis study looks at how a shorter tuberculosis (TB) treatment regimen works for children and adolescents with non-severe TB in Zambia. It involves children, caregivers, health workers, and policymakers to understand how well the regimen is accepted, followed, and feasible in real…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a nasal swab curb unnecessary antibiotic use?
Disease control CompletedThis trial examines whether using a quick nasal swab to check for MRSA bacteria can help doctors decide how long to treat pneumonia patients with the antibiotic vancomycin. The study compares the duration of therapy and costs before and after implementing this screening test. Par…
Sponsor: Methodist Health System • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Which antibiotic wins the battle against chlamydia in teens?
Disease control CompletedThis trial tests two approved antibiotics—azithromycin (a single dose) and doxycycline (twice daily for a week)—to see which is more effective at curing genital chlamydia in young people aged 12-21 living in youth correctional facilities. Participants provide urine samples over a…
Phase 3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a new antibiotic outperform standard care for pneumonia?
Disease control CompletedThis trial compares the antibiotic faropenem to a standard combination of co-amoxiclav and clarithromycin in adults with community-acquired bacterial pneumonia. Participants are randomly assigned to one of two treatment groups for seven days, then followed for four weeks. The stu…
Phase 4 • Sponsor: Dr. Md. Alimur Reza • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
When to add a second blood pressure drug in septic shock? large trial seeks answers
Disease control CompletedThis study looks at the best time to add the drug vasopressin for people with septic shock—a life-threatening drop in blood pressure from infection. About 2,050 adults will be treated using either an earlier or later threshold for starting vasopressin. The goal is to see which ap…
Phase 4 • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a week of antibiotics beat a kidney infection?
Disease control CompletedThis trial tests whether a 7-day antibiotic course—starting with an intravenous dose of ceftriaxone followed by oral cefixime—can effectively treat acute uncomplicated pyelonephritis (a kidney infection) in women aged 18 to 65. The goal is to see if this shorter regimen works as …
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a stronger antibiotic dose keep cellulitis patients out of hospital?
Disease control CompletedThis study tests whether a higher dose of the oral antibiotic cephalexin can better treat cellulitis, a common skin infection, in adults visiting the emergency room. About 446 participants will receive either a high or standard dose to see if it reduces the need for changing anti…
Phase 4 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a pill replace the syphilis shot? new trial tests oral antibiotic
Disease control CompletedThis trial compares an oral antibiotic called linezolid to the standard penicillin injection for treating early syphilis. Linezolid can reach the brain, which may help prevent neurosyphilis. About 224 adults with primary, secondary, or early latent syphilis will be randomly assig…
Phase 3 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
A smartphone app takes on heavy drinking and STIs in high-risk men
Disease control CompletedThis trial tests whether a web-based app called Game Plan can help men who have sex with men reduce heavy drinking and sexually transmitted infections. Participants receive home HIV/STI self-testing kits and are randomly assigned to either a 24-hour helpline alone or the helpline…
Sponsor: Brown University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could giving TB pills on day one save more lives?
Disease control CompletedThis study tested a new strategy: giving TB prevention medicine at the same time as TB testing to people with HIV starting or restarting antiretroviral therapy. The goal was to see if this approach gets more people on TB prevention quickly without missing active TB cases. The tri…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a simple chemical wash replace surgery for trapped lungs?
Disease control CompletedThis study tests whether injecting a diluted hydrogen peroxide solution or steroids into the chest can break up scar tissue and free a trapped lung, compared to a standard surgical scraping procedure (thoracoscopy). The trial enrolls adults aged 18-62 with a lung infection that h…
Phase 2 • Sponsor: Delta University for Science and Technology • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Shorter h. pylori treatment shows promise in new trial
Disease control CompletedThis trial tests whether a 7-day course of vonoprazan combined with high-dose amoxicillin and clarithromycin can eradicate H. pylori infection as effectively as the current 14-day extended sequential therapy. About 628 adults with H. pylori infection will be randomly assigned to …
Phase 4 • Sponsor: Fu Jen Catholic University Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Laser light may help save infected young teeth and speed root growth
Disease control CompletedThis trial tests whether using a low-power laser during a pulpotomy (removing infected pulp from a tooth) can improve healing and root formation in children aged 6 to 14 with painful, irreversible pulpitis in immature permanent molars. Participants receive either laser treatment …
Sponsor: Alexandria University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can a common antibiotic beat yaws? new trial puts linezolid to the test
Disease control CompletedThis phase 3 trial investigates whether the antibiotic linezolid can cure yaws, a bacterial skin infection that causes ulcers, as effectively as the standard treatment azithromycin. The study involves 384 children aged 5 to 18 with confirmed yaws. Participants receive either line…
Phase 3 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New Tooth-Saving material could spare kids from extractions
Disease control CompletedThis study tests whether a newer, easier-to-use material called NeoPUTTY works as well as the standard MTA for saving permanent back teeth with severe nerve inflammation in children aged 9 to 14. Both materials are used to cover the remaining healthy nerve after removing the dise…
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New study tests faster, less painful root canals for kids
Disease control CompletedThis trial compares two types of rotary files (Kedo-Nano Plus and Kedo-S Square) with traditional hand files for root canals in children's baby molars. About 60 healthy kids aged 5-8 with infected molars will receive a pulpectomy using one of the three tools. Researchers will che…
Sponsor: Goa Dental College • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Hospital care model aims to treat opioid addiction and serious infections together
Disease control CompletedThis study tests a care model where hospitalized adults with opioid use disorder and a serious infection receive long-acting injectable buprenorphine from their infectious disease doctors, alongside infection treatment. The goal is to keep patients on effective medication for opi…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a single abutment placement save your jawbone?
Disease control CompletedThis study tests whether placing the final abutment once during dental implant surgery, without removing it during healing, reduces bone loss around the implant compared to standard repeated disconnections. Researchers will also measure patient satisfaction and analyze mouth bact…
Sponsor: University of Valencia • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for kids with Drug-Resistant TB: bedaquiline studied in children
Disease control CompletedThis study looked at how safe and tolerable the drug bedaquiline is for children and teens with rifampin-resistant tuberculosis, including those also living with HIV. Fifty-four participants received bedaquiline along with their regular TB treatment for 24 weeks. Researchers meas…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug candidate takes on stubborn lung infection
Disease control CompletedThis study tests whether adding delpazolid to standard treatment can reduce bacterial levels in people with hard-to-treat Mycobacterium abscessus lung infections. Participants take delpazolid tablets daily for 12 weeks, with the option to continue up to one year if there is clini…
Phase 2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Infusion or bolus? study tests best steroid delivery for septic shock
Disease control CompletedThis trial compares two methods of giving hydrocortisone to adults with septic shock—a life-threatening drop in blood pressure due to infection. One group receives the steroid as a continuous drip, the other as intermittent shots every six hours. Researchers track 28-day survival…
Phase 4 • Sponsor: Benha University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New decolonization method could lower infection risk in spine surgery
Disease control CompletedThis pilot study compares a new decolonization regimen using polyhexanide (nasal gel and body foam) to the standard mupirocin and chlorhexidine treatment for reducing Staphylococcus aureus bacteria before elective spine surgery. The trial includes 24 adults who carry Staph bacter…
Phase 4 • Sponsor: Swiss Paraplegic Research, Nottwil • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a single antibiotic dose before hip replacement be just as effective as multiple doses?
Disease control CompletedThis trial investigates whether a single dose of antibiotics before hip replacement surgery prevents joint infections as effectively as multiple doses. The study involves about 20,000 adults with osteoarthritis undergoing hip replacement at hospitals across Denmark. Researchers w…
Sponsor: Soren Overgaard • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a simple blood test ensure the right TB dose for kids?
Disease control CompletedThis trial investigates whether the dose of rifapentine given to children aged 2 to 11 with latent tuberculosis infection is adequate. Researchers measure the drug level in a single blood sample taken 24 hours after a dose and compare it to levels in adults. The goal is to ensure…
Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a lower dose of an old antibiotic tame Drug-Resistant TB?
Disease control CompletedThis study tests whether a low daily dose of the antibiotic linezolid, added to a personalized combination of other drugs, is safe and tolerable for people with multidrug-resistant tuberculosis (MDR-TB). Participants take either linezolid or a placebo for 16 weeks, alongside thei…
Phase 1/2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can extra tdap shots boost Life-Saving plasma?
Disease control CompletedThis study looks at whether giving the Tdap vaccine every 3 months for a year is safe for healthy plasma donors. Normally, this vaccine is given once every 10 years. The goal is to see if more frequent vaccination produces high levels of tetanus antibodies in the plasma, which co…
Phase 2 • Sponsor: ABO Holdings, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New program aims to keep patients on track after Infection-Related hospitalizations
Disease control CompletedThis study tested a program to help people with opioid use disorder stay on their medication after being hospitalized for serious infections like endocarditis or bone infections. Forty adults took part to see if the program was practical and helpful. The goal is to improve long-t…
Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a smartphone replace the nurse? study tests video monitoring for TB treatment
Disease control CompletedThis study compares two ways of making sure people with tuberculosis (TB) take their medicine correctly: traditional in-person observation by a healthcare worker versus electronic observation using live video or recorded videos on a computer or phone. The trial involves 216 TB pa…
Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a blood clot replace root canal fillings? new study tests regenerative approach
Disease control CompletedThis study tests whether leaving a tooth's root canal unfilled and using a blood clot to trigger natural healing works as well as the standard root canal filling. The trial involves 48 men with infected but still living upper premolars. One group gets the standard gutta-percha fi…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a Two-Vaccine strategy better shield spleenless patients from pneumonia?
Disease control CompletedThis trial investigates whether giving two different pneumonia vaccines—one followed by another a year later—boosts immune protection more than a single vaccine alone in adults who have had their spleen removed. People without a spleen are at higher risk for serious pneumococcal …
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug naderin may help patients fight infections during cancer and TB therapy
Disease control CompletedThis study tested whether adding Naderin (sodium nucleinate) to standard treatment could reduce complications in 75 patients with cancer, tuberculosis, or hepatitis C. The main group received Naderin plus standard therapy, while the control group received standard therapy alone. …
Phase 2/3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids with Drug-Resistant TB: delamanid studied in children
Disease control CompletedThis study tested the drug delamanid in 37 children with multidrug-resistant tuberculosis (MDR-TB), some of whom also had HIV. The goal was to see how the drug works in the body, check for side effects, and find the right dose. Children took delamanid along with their regular TB …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New Staph-Fighting skin regimen shows promise in High-Risk community
Disease control CompletedThis study tested whether a combination of topical antibiotics and antiseptic washes could reduce staph bacteria on the skin of Native American adults living on or near tribal lands. Participants were at high risk for staph infections due to diabetes, obesity, or recent infection…
Phase 4 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Which antibiotic works best for hidden anal chlamydia?
Disease control CompletedThis study compared two common antibiotics—azithromycin (single dose) and doxycycline (7-day course)—for treating anal chlamydia in women who also had a vaginal chlamydia infection. The goal was to see which treatment clears the anal infection better, since anal chlamydia often g…
Phase 4 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could vitamin B12 help fight septic shock?
Disease control CompletedThis study tested whether giving a single high dose of vitamin B12 (5 grams) to 20 adults with septic shock is feasible and safe. Patients received either vitamin B12 or a placebo (saline) alongside standard care. The main goal was to see if the study procedures could be complete…
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a booster shot for the immune system prevent more infections in sepsis survivors?
Disease control CompletedThis study tested a drug called GM-CSF in 166 ICU patients who had severe sepsis or septic shock and a weakened immune system. The goal was to see if the drug could reduce the number of new infections acquired in the ICU. Patients received either GM-CSF or a placebo, and research…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
ICU ulcer prevention drug under scrutiny: does pantoprazole help or harm?
Disease control CompletedThis study tested whether giving pantoprazole (a stomach acid reducer) to critically ill ICU patients prevents stress ulcers and reduces death. Over 3,300 adults at high risk were randomly assigned to receive pantoprazole or a placebo daily while in the ICU. Researchers tracked d…
Phase 4 • Sponsor: Dr. Morten Hylander Møller • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for kids with Drug-Resistant TB: pretomanid dose study completed
Disease control CompletedThis study tested a single dose of the drug pretomanid in 32 children with rifampicin-resistant tuberculosis (TB). The goal was to see how the drug moves through the body and whether it is safe when added to their regular TB treatment. The children were monitored for 48 hours aft…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Next-Day clinic aims to cut hospital admissions for common ailments
Disease control CompletedThis study tested a new clinic that sees emergency room patients the next day for conditions like pneumonia, heart failure, and kidney injury. The goal was to avoid hospital stays and improve patient care. About 570 adults took part, and researchers measured how many days they we…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Vitamin c Mega-Dose tested against deadly sepsis
Disease control CompletedThis study tested whether giving very high doses of vitamin C to people with sepsis (a severe infection that can cause organ failure) could reduce the risk of death within 28 days. 234 adults in the ICU received either vitamin C or a placebo for up to 4 days. The main goal was to…
Phase 2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can less fluid save lives? new septic shock strategy tested
Disease control CompletedThis study tested a structured plan to remove excess fluid early in patients with septic shock. 170 ICU patients were randomly assigned to either the fluid removal protocol or standard care. The goal was to see if the plan could safely reduce fluid buildup by day three, which mig…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New way to deliver c. diff treatment: through a colonoscopy
Disease control CompletedThis study tested a treatment called RBX2660 (REBYOTA) for people with recurrent Clostridioides difficile infection. The treatment is made from healthy human stool bacteria and was given during a colonoscopy. The goal was to see if this delivery method is safe and works well. For…
Phase 3 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Sticker shock: simple picture boosts antibiotic use in UTI patients
Disease control CompletedThis study tested whether a visual storytelling sticker on antibiotic packaging helps adults with urinary tract infections (UTIs) take all their medicine. 358 adults in Pakistan were randomly assigned to get either the sticker or usual care. The goal was to see if the sticker imp…
Sponsor: Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New antibiotic flush could beat stubborn joint infections
Disease control CompletedThis study tested a device that delivers antibiotics directly to an infected hip or knee joint for 7 days after replacement surgery. 76 adults with joint infections were randomly assigned to get either the local antibiotic irrigation plus standard care, or standard care alone. Th…
Phase 2 • Sponsor: Osteal Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Ambulance crews test early antibiotics for sepsis
Disease control CompletedThis study tested whether paramedics can improve survival by giving antibiotics and fluids to sepsis patients before reaching the hospital. Over 2,000 adults with suspected sepsis and low blood pressure were enrolled. The goal was to see if early treatment in the field reduces de…
Phase 4 • Sponsor: Dr. Damon Scales • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for lung infection sufferers: inhaled antibiotic trial shows promise
Disease control CompletedThis study tested whether an inhaled antibiotic (tobramycin), taken alone or with an oral antibiotic (ciprofloxacin), can permanently clear Pseudomonas aeruginosa infections from the lungs of people with bronchiectasis. The trial involved 371 adults and compared these treatments …
Phase 4 • Sponsor: Jin-Fu Xu • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could adding calcium to ORS stop diarrhea faster?
Disease control CompletedThis study tested whether an oral rehydration solution (ORS) with added calcium works better than standard ORS for adults with severe watery diarrhea, including cholera. Researchers measured stool output, diarrhea duration, and other symptoms in 396 adults. The goal is to find a …
Phase 2/3 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New antibiotic cocktail takes on superbugs in phase 3 trial
Disease control CompletedThis study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best available treatments for adults with serious infections like urinary tract infections, pneumonia, and abdominal infections caused by carbapenem-resistant bacteria. Th…
Phase 3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a 2-Month TB prevention be as good as 4 months?
Disease control CompletedThis study tested whether taking a higher dose of the drug rifampin for 2 months is as safe and effective as the standard 4-month dose for treating latent tuberculosis (TB) infection. Over 1,300 adults and children aged 10 and older with latent TB were randomly assigned to receiv…
Phase 2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Flomax may prevent Post-Surgery urinary woes in older men
Disease control CompletedThis study tested whether tamsulosin (Flomax) can reduce the risk of urinary retention and catheter-related infections in men aged 50 and older after elective surgery. Participants received either tamsulosin or a placebo after their catheter was removed. The goal was to see if th…
Phase 3 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New bladder irrigation device aims to cut Post-Surgery infections
Disease control CompletedThis study tested a closed-system bladder irrigation device designed to reduce urinary tract infections after endoscopic urologic surgery. 240 patients undergoing prostate or bladder tumor surgery were randomly assigned to use the new device or standard irrigation. The device all…
Sponsor: University of Pisa • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Smarter dosing for kids with superbug infections?
Disease control CompletedThis study tested whether an early, computer-guided dosing strategy for vancomycin helps children with MRSA infections reach the right drug levels faster than the usual approach. 100 children aged 1 month to 16 years took part. The goal was to improve treatment effectiveness whil…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Antibiotic-Free future: study tests stopping trachoma treatment
Disease control CompletedThis study looked at whether it is safe to stop giving annual azithromycin to communities with low levels of trachoma, an eye infection that can cause blindness. Over 3,900 people in Niger took part. Researchers compared stopping treatment after at least 5 years versus continuing…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cat scratch cure? injection may shrink swollen nodes faster
Disease control CompletedThis study tested whether injecting the antibiotic gentamicin directly into swollen lymph nodes helps people with cat scratch disease recover faster. 75 participants received either the injection or a placebo, along with standard oral antibiotics. The goal was to see if the injec…
Phase 3 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Eye drop may prevent eyelash regrowth after trachoma surgery
Disease control CompletedThis study tested whether a steroid eye drop (fluorometholone) given for four weeks after trachoma surgery could stop eyelashes from growing back and rubbing against the eye. Over 2,400 people aged 15 and older took part. The goal was to see if this simple, low-cost addition to s…
Phase 3 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug shows promise against staph blood infections
Disease control CompletedThis study tested a new medicine called AP-SA02, given through a vein, along with standard antibiotics for adults with a Staph blood infection. The main goal was to check if the combination is safe and tolerable. Researchers also looked at whether it helped clear the infection fa…
Phase 1/2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Blue dye tested in septic shock: could it help ICU patients?
Disease control CompletedThis pilot study tested whether adding methylene blue to standard care is feasible for adults with septic shock in the intensive care unit. The main goal was to see if a larger trial could be done, not to prove the treatment works. Fifty patients took part, and the study looked a…
Phase 3 • Sponsor: Dr. Shannon M. Fernando • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can donor plasma fix clotting issues in sepsis? new study investigates
Disease control CompletedThis study tests whether a special donor plasma product called OctaplasLG can help people with septic shock who develop blood clotting problems. Sixty participants will receive either OctaplasLG or a placebo (salt water) to see if the treatment improves clotting and outcomes. The…
Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Pill power: oral antibiotic could replace IV for tough UTIs
Disease control CompletedThis study tested an oral antibiotic (tebipenem pivoxil hydrobromide) against a standard IV antibiotic in 1,690 hospitalized adults with complicated urinary tract infections or kidney infections. The goal was to see if the oral pill works as well as the IV treatment in curing the…
Phase 3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo shows promise against deadly gut infection
Disease control CompletedThis study tested whether adding the drug bezlotoxumab to standard treatment could prevent serious outcomes in people with a severe C. diff infection. Researchers used a special score to identify 44 high-risk patients. The goal was to see if the drug reduced organ failure, infect…
Phase 2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Which IV fluid is safer for kids with sepsis? major trial gives answers
Disease control CompletedThis large study tested whether a 'balanced' fluid (Lactated Ringer) is better than normal saline for children with septic shock. Over 9,000 kids participated across multiple hospitals. The goal was to see which fluid reduces the risk of serious kidney problems or death within 30…
Phase 3 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Drug-resistant typhoid in kids: does a two-drug combo speed up recovery?
Disease control CompletedThis study looked at whether giving two antibiotics together (meropenem and azithromycin) helps children with drug-resistant typhoid fever get better faster than using just one. 90 children aged 6 months to 5 years with confirmed typhoid took part. The main goal was to see how qu…
Phase 4 • Sponsor: Sheikh Zayed Medical College • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New antibiotic shows promise for newborns with dangerous infections
Disease control CompletedThis study looked at how the antibiotic cefiderocol works in hospitalized infants under 3 months old with suspected or confirmed gram-negative bacterial infections. Researchers measured drug levels in the blood and checked for side effects in 30 babies. The goal was to find the r…
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Saline vs. Ringer's: which fluid saves more lives in septic shock?
Disease control CompletedThis large trial tested whether a lower-chloride fluid (Ringer's Lactate) reduces death and kidney injury compared to standard saline in 1,113 adults with septic shock. Participants received either fluid within 6 hours of hospital arrival. The study aims to settle a long-standing…
Phase 2/3 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Village health workers cut deaths in remote indian tribes
Disease control CompletedThis large study in rural India trained village health workers to diagnose and treat common illnesses like high blood pressure, diarrhea, pneumonia, malaria, asthma, and COPD. Over 72,000 adults aged 16-60 from 80 tribal villages took part. The goal was to reduce deaths by at lea…
Phase 4 • Sponsor: MAHAN Trust • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Saline vs. drugs: a simpler way to treat lung infections?
Disease control CompletedThis study compared two treatments for pleural infection, a serious lung condition where infected fluid builds up. One group received standard fibrinolytic drugs (alteplase and DNase) to break down clots, while the other group received simple saline (salt water) irrigation to flu…
Sponsor: National University of Malaysia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can less be more? new study tests cutting antibiotics in cancer patients with sepsis
Disease control CompletedThis study looked at whether reducing the use of strong, broad-spectrum antibiotics in cancer patients with sepsis or septic shock is as safe as continuing them. The goal is to lower the risk of creating drug-resistant bacteria. Researchers compared a de-escalation strategy to st…
Phase 3 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could 'Good' bacteria beat a common vaginal infection?
Disease control CompletedThis study tested whether vaginal capsules containing live lactobacilli (good bacteria) are safe and tolerable for treating bacterial vaginosis (BV), a common infection. Fifty-seven women with BV took either the lactobacillus capsules or the standard antibiotic metronidazole. The…
Phase 2 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Probiotic capsules take on bacterial vaginosis in major trial
Disease control CompletedThis study tested whether vaginal probiotic capsules can cure bacterial vaginosis (BV) better than a placebo. 402 women with BV took part. The main goal was to see if more women were cured 21-30 days after treatment with the probiotic compared to placebo. The trial was completed …
Phase 3 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could probiotic capsules beat bacterial vaginosis?
Disease control CompletedThis study tested whether vaginal capsules containing two types of Lactobacillus probiotics can treat bacterial vaginosis, a common vaginal infection. Sixty-six women received either the probiotic capsule or a placebo. The goal was to see if the probiotics could restore normal va…
Phase 2 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could fewer antibiotics be better for MAC lung disease?
Disease control CompletedThis study tested whether taking two antibiotics instead of three is just as effective for treating a lung infection called MAC, while causing fewer side effects. 474 adults with MAC lung disease were randomly assigned to receive either two or three drugs for 12 months. The goal …
Phase 2/3 • Sponsor: Kevin Winthrop • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Inhaled antibiotic shows promise against stubborn lung infection
Disease control CompletedThis study tested whether adding an inhaled antibiotic (ALIS) to standard oral antibiotics helps adults with a new diagnosis of a hard-to-treat lung infection caused by MAC bacteria. About 425 adults took part. The main goal was to see if the combination improved breathing sympto…
Phase 3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New antibiotic shows promise against superbug blood infections
Disease control CompletedThis study tested whether an older antibiotic, temocillin, works as well as the standard treatment meropenem for bloodstream infections caused by drug-resistant bacteria. 334 adults with these infections were randomly assigned to receive one of the two antibiotics for 7 to 14 day…
Phase 3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Double antibiotic attack could beat typhoid resistance
Disease control CompletedThis study tested whether a combination of two antibiotics (azithromycin and cefixime) works better than azithromycin alone for treating uncomplicated typhoid fever in South Asia. Over 2,100 patients took part across Bangladesh, India, Nepal, and Pakistan. Researchers measured tr…
Phase 4 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New two-drug combo may beat standard four-drug therapy for stomach bug
Disease control CompletedThis study tested whether a simpler two-drug treatment (tegoprazan and amoxicillin) works better than the standard four-drug therapy for eradicating H. pylori, a bacteria that can cause stomach ulcers. 370 adults with H. pylori infection were randomly assigned to one of the two t…
Phase 4 • Sponsor: Zhang Xiaofeng,MD • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could shorter antibiotics work just as well for newborns?
Disease control CompletedThis study looked at whether giving antibiotics for a shorter, personalized time is as safe and effective as the usual 7-day course for full-term newborns with a suspected infection. About 488 babies took part across 18 hospitals. The goal was to see if shorter treatment could re…
Phase 4 • Sponsor: Ulrikka Nygaard • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Shorter h. pylori treatment may work just as well as longer one
Disease control CompletedThis study looked at 508 adults with H. pylori infection to see if a 7-day triple therapy (vonoprazan, amoxicillin, tetracycline) works as well as a 14-day dual therapy (vonoprazan, amoxicillin). The goal was to compare how often the infection is cleared and how many side effects…
Sponsor: Yueyue Li • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Virus cocktail inhaled to fight Drug-Resistant lung infection
Disease control CompletedThis study tested an inhaled mixture of bacteria-killing viruses (phages) in 48 adults with bronchiectasis and chronic Pseudomonas lung infections. Participants received either the phage therapy or a placebo by inhalation. The goal was to see if the phages could safely reduce the…
Phase 2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Which works better for h. pylori? triple vs quadruple therapy showdown
Disease control CompletedThis study tested two different 14-day drug combinations to treat Helicobacter pylori, a bacteria that causes stomach inflammation and ulcers. Over 750 adults were randomly assigned to either a triple therapy (omeprazole, amoxicillin, clarithromycin) or a quadruple therapy (omepr…
Phase 4 • Sponsor: Azfar Farogh • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New antibiotic cocktails take on tough UTIs and kidney infections
Disease control CompletedThis phase 3 trial tested two new antibiotic combinations—cefepime/nacubactam and aztreonam/nacubactam—against a standard antibiotic (imipenem/cilastatin) in 614 adults with complicated urinary tract infections or acute kidney infections. The goal was to see if the new combos are…
Phase 3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Shorter antibiotic course could spare joint infection patients weeks of treatment
Disease control CompletedThis study compared 6 weeks versus 12 weeks of antibiotics for people with infected hip or knee prostheses who had surgery. Researchers wanted to see if the shorter course was just as effective at curing the infection without increasing relapse. The trial enrolled 410 adults acro…
Phase 3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can higher doses and steroids beat TB in HIV patients?
Disease control CompletedThis study tested whether a stronger tuberculosis (TB) treatment could save more lives in people with HIV and very weak immune systems. Over 1,300 hospitalized patients received either the standard TB drugs or an intensified version with higher doses of two key medicines, plus a …
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a simple salt solution help septic shock patients?
Disease control CompletedThis pilot study tested whether giving a sodium lactate solution to people with septic shock could help manage their fluid balance. Septic shock is a life-threatening condition where blood pressure drops dangerously due to infection. The study involved 59 participants and compare…
Phase 2/3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Smart software aims to perfect antibiotic dosing in septic shock
Disease control CompletedThis study tested whether a computer program called BestDose could help doctors give the right amount of the antibiotic amikacin to patients with septic shock. The goal was to get drug levels in the ideal range after the second dose. 180 patients took part, and researchers checke…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Dead teeth revived with pulp transplant in small trial
Disease control CompletedThis study tested whether transplanting pulp tissue from a healthy tooth into a dead one could restore vitality. Twenty-one adults with dead single-rooted teeth received either a pulp transplant, a pulp transplant with growth factors, or standard root canal treatment. The goal wa…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a vaccine speed up TB recovery?
Disease control CompletedThis study tested a therapeutic vaccine called RUTI in 41 adults with active pulmonary tuberculosis. Participants received either the vaccine or a placebo alongside their regular antibiotic treatment. The goal was to see if the vaccine could boost the immune system to kill bacter…
Phase 2 • Sponsor: Archivel Farma S.L. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Which antibiotic wins for skin infections? study pits doxycycline against TMP-SMX
Disease control CompletedThis study compared two common antibiotics, doxycycline and TMP-SMX, for treating uncomplicated skin infections like boils and cellulitis. 269 people aged 9 to 85 took one of the drugs for 7 days. Researchers checked if the infection cleared up early, at the end of treatment, and…
Phase 2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a probiotic pill restore vaginal balance? new study explores
Disease control CompletedThis study tested whether an oral probiotic supplement could help restore healthy bacteria in the vagina. It included 32 women aged 35-43 with vaginal imbalance and fertility concerns. Researchers measured how well the probiotic colonized the body and its effects on immune and an…
Sponsor: Fertypharm • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Antibiotic showdown: which drug works best for staph blood infection?
Disease control CompletedThis study compared two antibiotics, cloxacillin and cefazolin, in 315 adults with a serious bloodstream infection caused by methicillin-susceptible Staphylococcus aureus (MSSA). The goal was to see if cefazolin works as well as cloxacillin, the standard treatment, while potentia…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can a Double-Dose vaccine strategy shield vulnerable vasculitis patients?
Disease control CompletedThis study tested whether giving a stronger pneumococcal vaccine schedule (either two doses close together or a single larger dose) followed by a standard booster could improve immune protection in 96 adults with ANCA-associated vasculitis who are also receiving rituximab therapy…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New antibiotic match for tough UTIs?
Disease control CompletedThis study tested if the antibiotic temocillin works as well as a stronger antibiotic (carbapenem) for treating urinary tract infections caused by resistant bacteria. 29 hospitalized adults took part. The goal was to see if both treatments could clear the infection and symptoms. …
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Arm cuff procedure tested to fight organ failure in septic shock
Disease control CompletedThis study tested whether a non-invasive arm cuff procedure, called remote ischemic conditioning, could reduce organ failure in 180 adults with septic shock. The cuff was inflated and deflated in cycles to mimic brief blood flow restriction. The goal was to see if this could prot…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Hospital study tests decolonization to stop superbug infections
Disease control CompletedThis study tested whether a 5-day decolonization routine using nasal ointment, mouth rinse, and body wash could prevent MRSA infections in over 2,000 adults carrying the bacteria after hospital discharge. Participants were randomly assigned to either the decolonization regimen or…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Which antibiotic wins against this tough lung bug?
Disease control CompletedThis study tested two different antibiotics—clarithromycin or moxifloxacin—alongside standard drugs to treat a rare lung infection caused by M. xenopi bacteria. Researchers tracked whether patients' sputum samples became bacteria-free after 6 months. The goal was to find the more…
Phase 3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Brain surgery infection fighter: vancomycin powder put to the test
Disease control CompletedThis study tested whether applying vancomycin powder directly to the surgical wound during brain surgery can reduce infections. Over 1,100 adults having neurosurgery were randomly assigned to receive either the topical vancomycin or standard care. The main goal was to see if the …
Phase 3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New combo pill shows promise for HIV patients fighting TB
Disease control CompletedThis study tested a new HIV medication (Biktarvy) taken twice daily in 122 adults who also have drug-sensitive tuberculosis (TB) and are on standard TB treatment. The goal was to see if the new pill can control HIV just as well as the current standard treatment. The study measure…
Phase 2 • Sponsor: Centre for the AIDS Programme of Research in South Africa • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could early CMV and TB drugs save HIV-Positive babies with pneumonia?
Disease control CompletedThis study tested whether giving HIV-infected infants with severe pneumonia early treatment for cytomegalovirus (CMV) and tuberculosis (TB) could help them survive. Over 500 babies aged 1 month to 1 year were randomly assigned to receive either standard care or additional drugs f…
Phase 2/3 • Sponsor: Hospital Universitario 12 de Octubre • Aim: Disease control
Last updated Jun 26, 2026 18:55 UTC
-
New fluid strategy aims to reduce organ failure in septic shock
Disease control CompletedThis study tested a personalized approach to fluid management in 535 adults with septic shock. Doctors used a 'mini-fluid challenge'—a small amount of albumin given quickly—to check if more fluids would help, aiming to avoid fluid overload. The goal was to see if this tailored me…
Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 26, 2026 18:50 UTC
-
New TB drug combo shows promise in early trial
Disease control CompletedThis phase IIb trial tested an experimental antibiotic called delpazolid, added to a standard three-drug regimen (bedaquiline, delamanid, moxifloxacin), in 76 adults with newly diagnosed, drug-sensitive pulmonary tuberculosis. The main goals were to check safety and how the drug …
Phase 2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:01 UTC
-
Blood test could shorten antibiotic course for newborns with sepsis
Disease control CompletedThis study tested whether measuring a blood marker called procalcitonin (PCT) could help doctors decide when to stop antibiotics in newborns with late-onset sepsis. Over 500 newborns were included, and the goal was to reduce antibiotic use by 30% without increasing infection recu…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 15:44 UTC
-
Which UTI antibiotic works best? new study compares four options
Disease control CompletedThis study tested four different short antibiotic courses in 1,000 women with uncomplicated lower urinary tract infections. Participants received either a two-day course of fosfomycin, a three-day course of pivmecillinam, a five-day course of nitrofurantoin, or a single dose of f…
Phase 4 • Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Disease control
Last updated Jun 26, 2026 14:59 UTC
-
Can immune antibodies fight toxic shock in kids? small trial hopes to find out
Disease control CompletedThis study tested whether giving intravenous immunoglobulin (IVIG) to children with toxic shock syndrome is practical and might help. Toxic shock is a rare but life-threatening reaction to bacterial toxins. The trial enrolled 30 children in intensive care, giving them either IVIG…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 14:21 UTC
-
Ultrasound could offer a clearer window into joint infections
Diagnosis CompletedResearchers are testing whether ultrasound can reliably show joint damage and inflammation in people with septic arthritis, a painful joint infection. The trial follows 28 adults with septic arthritis in the shoulder, elbow, wrist, hip, knee, or ankle. Participants receive standa…
Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
A simple blood test may spot severe bacterial infections faster in the ER
Diagnosis CompletedResearchers in Basel are testing whether a blood marker called HNL can help emergency doctors quickly tell whether an infection is bacterial or viral. The study will enroll about 516 adults with suspected infection and signs of physiological disturbance. Doctors will measure HNL …
Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
A single swab, two diseases: rapid test takes on TB and COVID-19
Diagnosis CompletedResearchers are testing a portable device called Truenat MTB Plus/COVID-19 to see if it can accurately detect both tuberculosis and COVID-19 from the same sample. The study will enroll about 2,000 adults who have symptoms like a long-lasting cough, fever, or weight loss, which co…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
New tests aim to outsmart superbug gonorrhea
Diagnosis CompletedThis study is testing three new diagnostic tests to see if they can correctly identify a gene mutation that makes gonorrhea resistant to the antibiotic ciprofloxacin. Researchers will use leftover samples from over 3,000 people who already tested positive for gonorrhea. If the te…
Sponsor: Duke University • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Can newer tests match the gold standard for detecting Drug-Resistant TB?
Diagnosis CompletedThis study evaluates whether two newer line probe assays, the YD REBA MTB-MDR and Hain Genotype MTBDRplus V2, perform as well as the older Hain Genotype MTBDRplus V1 in detecting drug-resistant tuberculosis. Researchers will test stored, de-identified samples from adults with sym…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Rapid dual test for HIV and syphilis could save newborns in guatemala
Diagnosis CompletedThis study tested a rapid fingerstick test that checks for both HIV and syphilis at the same time in pregnant women visiting prenatal clinics in Guatemala. The goal was to see if this quick, on-the-spot screening would lead to more women being diagnosed and treated during pregnan…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
Beyond TB: could a deeper diagnostic look uncover hidden lung diseases?
Diagnosis CompletedThis study tests whether an enhanced diagnostic workup can identify lung diseases other than tuberculosis in patients who are about to start TB treatment based on clinical signs but have negative sputum tests. Participants will undergo a thorough review and possibly additional te…
Sponsor: Stichting Longartsen voor Afrika • Aim: Diagnosis
Last updated Aug 27, 2026 00:00 UTC
-
A new blood marker may outperform lactate in predicting septic shock survival
Diagnosis CompletedThis study asks whether changes in blood renin levels over the first 72 hours can predict death in septic shock patients better than the standard lactate test. Researchers will measure renin and lactate at enrollment and at 24, 48, and 72 hours in 60 adults with septic shock. The…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
A drop of urine, a world of difference: new test could spot hidden infections
Diagnosis CompletedThis study is testing whether a new urine analysis device, the Sysmex UF-5000, can accurately measure inflammation markers in healthy men. The goal is to establish a baseline for what's normal, which could help develop a quick, non-invasive test for urethritis, a common infection…
Sponsor: Indiana University • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
Can a closer look at the stomach spot hidden infections?
Diagnosis CompletedThis trial compares two endoscopic techniques—standard white light endoscopy and magnifying endoscopy with narrow-band imaging—to see which better identifies the status of Helicobacter pylori (Hp) infection. About 384 participants will undergo both procedures, and the accuracy of…
Sponsor: Jilin University • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Tooth blood test could tell if a root canal is really needed
Diagnosis CompletedThis study looks at whether substances in the blood from a tooth's pulp can help dentists tell the difference between reversible pulpitis (a mild inflammation that can heal) and irreversible pulpitis (severe damage needing a root canal). Researchers will collect a small sample of…
Sponsor: Safa • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
A 5-hour test may replace days of waiting for the right antibiotic in blood infections
Diagnosis CompletedThis trial tests whether a rapid diagnostic test called Reveal can improve outcomes for hospitalized patients with gram-negative bloodstream infections. The test measures bacterial growth by detecting gases they release, giving results in about 5 hours instead of the usual 2-3 da…
Sponsor: Duke University • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
A dipstick test for joint infection? study puts cheap diagnostics to the test
Diagnosis CompletedThis study investigates whether three common lab tests — blood levels of ESR and CRP, plus a leukocyte esterase dipstick test on joint fluid — can reliably diagnose chronic infection in people who have had a total joint replacement. The researchers will compare the test results a…
Sponsor: Ain Shams University • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
New rapid test could free TB patients from isolation sooner
Diagnosis CompletedThis study evaluates a rapid viability test for tuberculosis bacteria in sputum samples. The goal is to see if this test can accurately tell whether a patient is still contagious, compared to the standard culture method that takes weeks. If the test works, it could help doctors d…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
New mass spec test could spot lyme disease faster
Diagnosis CompletedThis study tested a new diagnostic method (mass spectrometry) to detect Lyme disease bacteria in skin biopsies from 84 people with early Lyme rash (erythema migrans). The new method was compared to standard PCR and culture tests. The goal was to see if the new technique could ide…
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Rapid STI test aims to curb antibiotic misuse
Diagnosis CompletedThis study compares a new rapid point-of-care test for chlamydia, gonorrhea, and mycoplasma genitalium to standard lab testing. The goal is to see if the faster test helps doctors give the right antibiotics on the same day, reducing unnecessary or missed treatments. Participants …
Sponsor: Hoffmann-La Roche • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Urine test may predict kidney recovery in septic shock patients
Diagnosis CompletedThis study tested whether a urine test measuring two proteins (TIMP2 and IGFBP7) can tell which septic shock patients will recover normal kidney function within 72 hours. Researchers analyzed data from 77 patients in French ICUs. The goal is to help doctors decide who needs aggre…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New DNA method may spot hidden joint infections faster
Diagnosis CompletedThis study tested a new DNA-based technique called shotgun metagenomics to see if it can diagnose chronic infections in artificial joints better than standard lab cultures. Researchers took samples from 144 adults undergoing surgery for a suspected joint infection. The goal was t…
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Could a simple skin test uncover silent TB?
Diagnosis CompletedThis study tested a new skin test called C-TST to find latent (hidden) tuberculosis infections in 300 adults in Indonesia who were close contacts of TB patients. Participants received both the skin test and a standard blood test (IGRA) to see how well the new test worked. The goa…
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New test could speed up scrub typhus diagnosis
Diagnosis CompletedThis study tested a new molecular test (iiPCR) to diagnose scrub typhus, a bacterial infection spread by mites. Researchers compared the test's accuracy against standard methods in 345 participants in Thailand. The goal was to see if this tool could provide faster, reliable diagn…
Sponsor: University of Oxford • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
New combo test aims to spot ventilator pneumonia faster
Diagnosis CompletedThis study looked at 173 adults on ventilators to see if combining advanced germ-detection tests with a patient's immune response can improve diagnosis of ventilator-associated pneumonia. Researchers compared several molecular tests and host-response markers to standard clinical …
Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
Rapid HIV tests could end the epidemic by diagnosing in minutes
Diagnosis CompletedThis study tested three rapid, point-of-care HIV tests to see how well they work compared to standard lab tests. Researchers enrolled 224 adults at high risk for HIV in Baltimore. The goal was to see if faster results help more people start treatment or prevention the same day.
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Quick vaginal infection test could beat standard diagnosis
Diagnosis CompletedThis study tested whether a rapid point-of-care test (Xpert® Xpress MVP) helps doctors diagnose vaginal infections more accurately than usual methods. 351 women with symptoms like discharge or itching were randomly assigned to either usual care or the rapid test. Researchers then…
Sponsor: Sharon L Hillier • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New DNA test could speed up TB diagnosis, reduce need for invasive biopsy
Diagnosis CompletedThis study looked at whether measuring TB DNA in fluid from around the lungs (pleural fluid) can quickly and accurately diagnose tuberculosis. Researchers tested fluid from 329 adults with lung fluid buildup. The goal was to see if this DNA test works better than standard tests, …
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
New rapid test could slash TB diagnosis time in High-Burden regions
Diagnosis CompletedThis study tested a new rapid blood test called SeroSelectTB to see if it can diagnose active tuberculosis (TB) faster than current methods. Over 9,000 adults in South Africa, Tanzania, and Ethiopia who were unwell and suspected of having TB or pneumonia took part. The goal is to…
Sponsor: Norwegian Institute of Public Health • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Could a simple stool test revolutionize TB diagnosis for kids and HIV patients?
Diagnosis CompletedThis study evaluated a new stool-based test (qPCR) to diagnose tuberculosis (TB) in children under 8 and people living with HIV. Researchers in Mozambique, Eswatini, and Uganda tested nearly 2,000 participants to see if the stool test could improve TB detection rates compared to …
Sponsor: Barcelona Institute for Global Health • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Grinding up samples: a better way to spot bone infections?
Diagnosis CompletedThis study tested two ways of preparing tissue samples to find bacteria in bone and joint infections. One method grinds the sample, while the other uses standard techniques. Researchers wanted to see which method is more accurate at diagnosing infections. The study involved 122 p…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
New test could cut blood infection diagnosis from days to hours
Diagnosis CompletedThis study tested a new rapid test (OCEAN Dx) to identify bacteria in the blood of 110 ICU patients with suspected sepsis. The goal was to see if it works as well as standard blood cultures, which take 48-72 hours. A faster result could help doctors choose the right antibiotics s…
Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New infection score may improve burn care
Diagnosis CompletedThis study tested a new, low-cost tool called the Intensive Care Infection Score (ICIS) to see if it can better detect bacterial infections in burn patients compared to standard blood tests. Researchers studied 97 adults and children hospitalized for burns. The goal was to improv…
Sponsor: Charles University, Czech Republic • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
New blood test could spot dangerous infections in feverish kids faster
Diagnosis CompletedThis study looked at whether a combination of 7 biomarkers in the blood can more accurately diagnose severe bacterial infections in children aged 7 days to 36 months with fever. Researchers enrolled 983 children and compared the biomarker panel's performance against standard test…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Breakthrough test could save kids from deadly TB meningitis
Diagnosis CompletedThis study aimed to create a quick, simple test to diagnose tuberculous meningitis (TBM) in children. TBM is a severe form of TB that affects the brain and is hard to detect with current methods, especially in places with limited resources. Researchers tested 51 inflammatory mark…
Sponsor: University of Stellenbosch • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New rapid test could help fight superbugs in veterans
Diagnosis CompletedThis completed study tested a new rapid diagnostic tool to quickly identify antibiotic-resistant bacteria in wounded warriors and veterans. Over 2,200 participants provided samples from blood, lungs, or skin. The goal was to see if the test could accurately detect resistant bacte…
Sponsor: Connie Price • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Simple new device could speed up blood infection diagnosis in africa
Diagnosis CompletedThis study tested a new, portable blood culture system called BactInsight in hospitals in Benin and Burkina Faso. The system uses a battery-powered device to detect bacteria in blood samples faster than current manual methods. Researchers compared it to standard lab tests in over…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Massive global study aims to speed up TB diagnosis at local clinics
Diagnosis CompletedThis completed study tested several tuberculosis (TB) diagnostic tools in over 14,000 people across seven countries. The goal was to find tests that are accurate enough to use in local clinics, without needing special lab equipment. Researchers looked at a simple blood test for C…
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Emergency room study aims to catch more STIs in teens
Diagnosis CompletedThis study looked at better ways to screen teenagers (ages 15-21) for chlamydia and gonorrhea when they visit emergency departments. Researchers compared offering STI tests to everyone versus only to those with certain risk factors. The goal was to find the most effective and cos…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
New rapid tests aim to stop STIs in their tracks for pregnant women in zimbabwe
Diagnosis CompletedThis study tested a strategy of using rapid, point-of-care diagnostic tests for sexually transmitted infections (STIs) in pregnant women attending antenatal clinics in Zimbabwe. Over 1,000 women were offered testing for chlamydia, gonorrhea, trichomoniasis, syphilis, and hepatiti…
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Can a chest X-Ray and blood test quickly rule out TB?
Diagnosis CompletedThis study tested two new tools for diagnosing tuberculosis (TB): a software that analyzes chest X-rays (CAD4TB) and a blood test that measures C-reactive protein (CRP). Researchers enrolled 1,400 adults with TB symptoms in Lesotho and South Africa. They compared these tests to s…
Sponsor: Klaus Reither • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New blood test could slash unnecessary antibiotics in sick newborns
Diagnosis CompletedThis study tested whether a combination of 11 blood markers can more accurately diagnose late-onset sepsis in newborns in the NICU. Current methods are slow and often lead to unnecessary antibiotic use. Researchers enrolled 233 newborns with signs of infection to see if this biom…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 26, 2026 13:26 UTC
-
Can school lessons boost teen vaccine uptake?
Prevention CompletedResearchers compare one French middle school that used the e-Bug educational programme with other schools in the region to see whether classroom lessons about vaccination relate to higher HPV and meningococcal ACWY vaccine coverage. The study uses only aggregated, anonymised vacc…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Could a 5-Minute nasal light zap stop surgical infections?
Prevention CompletedThis completed trial tested a device that uses light to kill germs in the nose before surgery, aiming to prevent surgical site infections. Over 400 adults having major surgeries received either the light treatment or standard care. Researchers tracked infections and side effects …
Sponsor: Ondine Biomedical Inc. • Aim: Prevention
Last updated Sep 17, 2026 00:00 UTC
-
Nasal light zaps infection risk before surgery
Prevention CompletedThis study tested a new way to prevent surgical site infections by using a special light treatment inside the nose just before surgery. Over 4,700 adults having major surgeries like heart, spine, or joint replacement took part. The goal was to see if this light therapy reduces in…
Phase 3 • Sponsor: Ondine Biomedical Inc. • Aim: Prevention
Last updated Sep 17, 2026 00:00 UTC
-
Which antibiotic cocktail best shields vascular surgery patients from MRSA?
Prevention CompletedResearchers are comparing two antibiotic combinations given before vascular surgery to see which better prevents MRSA infections. Adults scheduled for procedures such as carotid surgery or dialysis access creation receive either vancomycin plus cefazolin or daptomycin plus cefazo…
Sponsor: CAMC Health System • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
A simple idea to stop STIs: send treatment home with the patient
Prevention CompletedThis trial tests a strategy called expedited partner therapy (EPT) for men who have sex with men in Peru. When a participant is diagnosed with gonorrhea or chlamydia, they receive antibiotic packets to give to their recent sexual partners, so those partners can get treated withou…
Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Can a Lab-Made antibody outperform standard tetanus shots?
Prevention CompletedThis phase 3 trial compares a new lab-made antibody, TNM002, with the standard human tetanus immunoglobulin for preventing tetanus in adults with dirty or contaminated wounds. Participants receive one injection of either treatment, and researchers measure whether their blood reac…
Phase 3 • Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Can a new vaccine safely shield babies from meningitis?
Prevention CompletedThis trial is testing the safety of the Menhycia® vaccine in about 3,000 healthy 3-month-old infants who have not yet received any epidemic meningitis vaccine. The infants will receive three doses of the vaccine at least one month apart, with an optional booster at 12 months of a…
Phase 4 • Sponsor: CanSino Biologics Inc. • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
One dose, big hope: antibiotic may stop cholera in kids
Prevention CompletedThis trial tests whether giving children a single dose of the antibiotic azithromycin right after a household member tests positive for cholera can prevent them from getting infected. The study enrolls children aged 1 to 15 who share cooking facilities with a cholera patient. Res…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Can a new vaccine shield older kids and adults from three deadly infections?
Prevention CompletedThis early-stage trial is testing an experimental vaccine designed to protect people aged 6 and older against diphtheria, tetanus, and pertussis (whooping cough). The study will enroll 180 participants to check the vaccine's safety and how well it triggers an immune response. Som…
Phase 1 • Sponsor: CanSino Biologics Inc. • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Can a new vaccine shield adults from four meningitis strains?
Prevention CompletedThis trial is testing an experimental vaccine called Menhycia, designed to protect against four types of meningococcal bacteria (A, C, Y, and W135) that can cause meningitis and bloodstream infections. The study involves about 1,480 healthy adults aged 18 to 55, who will receive …
Phase 3 • Sponsor: CanSino Biologics Inc. • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Can a new vaccine shield teens from meningitis?
Prevention CompletedThis trial is testing an experimental vaccine designed to protect against four strains of the bacteria that cause meningococcal meningitis, a serious infection of the brain and spinal cord. The study involves around 840 participants aged 7 to 17, who will receive either the new v…
Phase 3 • Sponsor: CanSino Biologics Inc. • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Can a single shot keep tetanus at bay?
Prevention CompletedThis trial is testing whether a single dose of an experimental tetanus vaccine is safe and triggers a protective immune response in adults aged 18 and older. Participants will receive either the new vaccine or a control vaccine, and researchers will measure antibody levels and mo…
Phase 3 • Sponsor: CanSino Biologics Inc. • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
Could giving TB meds at home boost prevention?
Prevention CompletedThis study tested whether giving a full 3-month supply of TB preventive medicine directly in the community helps more people finish their treatment compared to standard clinic visits. Researchers enrolled 301 adults in South Africa who were at risk for TB, including those with HI…
Sponsor: University of Washington • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Could routine STI screening during pregnancy prevent preterm births?
Prevention CompletedThis study compares different ways of screening pregnant women for three common sexually transmitted infections (chlamydia, gonorrhea, and trichomonas) to see if treating these infections can reduce the risk of preterm birth and low birth weight. Over 2,200 pregnant women in Sout…
Sponsor: Foundation for Professional Development (Pty) Ltd • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
Hospital push could shield seniors from preventable diseases
Prevention CompletedThis trial evaluates whether a hospital-based remedial vaccination strategy can improve Tdap-IPV (tetanus, diphtheria, pertussis, polio) vaccination rates in adults aged 65 and older in the Sarthe region of France. Participants are randomly assigned to receive either the remedial…
Sponsor: Centre Hospitalier le Mans • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Could a probiotic plus smart antibiotic use end the cycle of recurrent UTIs in children?
Prevention CompletedThis early-phase trial tests whether taking a daily probiotic (Saccharomyces boulardii) and using a targeted antibiotic (ciprofloxacin) only when a UTI occurs can reduce the number of repeat infections in children aged 2 to 17. Participants have had at least three UTIs in the pas…
Early phase 1 • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
App and peer support aim to boost HIV prevention for people leaving jail
Prevention CompletedThis study tested whether a mobile app (GeoPassport), financial incentives, and peer mentor support could help men who have sex with men and transgender women leaving jail access HIV prevention services like PrEP and testing. 233 participants were enrolled and followed for 9 mont…
Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
New TB prevention pack tested in thousands of thai households
Prevention CompletedThis completed study tested a new public health pack to find and prevent tuberculosis (TB) early in people living with someone who has TB. Over 7,400 participants in Thailand were involved. The pack included active screening, treatment for active TB, and preventive therapy for th…
Sponsor: Institut de Recherche pour le Developpement • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Can a pill and a vaccine stop STIs in High-Risk men?
Prevention CompletedThis study tested two strategies to prevent sexually transmitted infections (STIs) in men who have sex with men and already take HIV PrEP. One group took doxycycline pills after unprotected sex, and another group received a meningitis vaccine (Bexsero). The goal was to see if the…
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
One shot, two protections? new study combines e. coli and flu vaccines for seniors
Prevention CompletedThis study tested whether a new vaccine against certain E. coli bacteria (ExPEC9V) can be given at the same time as a high-dose flu shot in adults aged 65 and older. The goal was to see if the immune response to both vaccines remains strong when given together. About 959 particip…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
MRSA prevention: could a clean home and medicated wash stop infections?
Prevention CompletedThis study tested whether combining personal hygiene (using medicated washes and ointments) with household cleaning can prevent MRSA skin infections. Over 800 people from households with a recent MRSA infection took part. The goal was to see if this combined approach reduces the …
Phase 4 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
New vaccine strategy aims to shield lymphoma patients from deadly infections
Prevention CompletedThis study tested a two-step vaccine approach to prevent pneumococcal infections in 26 adults with diffuse large B-cell lymphoma who were receiving chemotherapy with rituximab. The vaccines, Prevenar and Pneumovax, were given in a prime-boost sequence to boost immune protection. …
Phase 3 • Sponsor: University Hospital, Tours • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Could a Spider-Silk bandage slash surgery infections?
Prevention CompletedThis study tested a special dressing coated with a spider-silk-like chemical (DACC) to see if it prevents infections after vascular surgery. Over 700 adults in the UK were randomly assigned to get either the DACC dressing or a standard one. Researchers checked for infections at 3…
Sponsor: Hull University Teaching Hospitals NHS Trust • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Real-world data shows REBYOTA™ may stop c. diff from coming back
Prevention CompletedThis observational study followed 145 adults who received REBYOTA™ to prevent another Clostridioides difficile infection (CDI) after completing antibiotics. Researchers collected information from medical records over 6 months to see how many people stayed infection-free. The goal…
Sponsor: Ferring Pharmaceuticals • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Could a simple antibiotic taper stop c. diff relapse?
Prevention CompletedThis study tested whether extending standard vancomycin treatment for C. diff infection with a 2-week taper (lowering the dose gradually) reduces the chance of the infection returning. 263 adults who had a first episode or first recurrence of C. diff were randomly assigned to rec…
Phase 3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Stool transplant plus antibody drug shows promise against recurrent c. diff in IBD patients
Prevention CompletedThis study tested whether combining a fecal microbiota transplant (FMT) with the drug bezlotoxumab could prevent repeat Clostridium difficile infections in people with inflammatory bowel disease (IBD). Sixty-one adults with at least two prior C. diff infections were randomly assi…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Pharmacist teamwork boosts pneumonia vaccine rates in hospitals
Prevention CompletedThis study tested whether a structured collaboration between pharmacists and doctors could improve pneumococcal vaccination rates in patients at high risk for infection. Over 600 hospitalized adults with chronic conditions or weakened immune systems took part. The pharmacist revi…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Cranberry capsules tested to stop catheter infections after surgery
Prevention CompletedThis study looked at whether cranberry gel capsules can prevent E. coli infections from urinary catheters placed during pelvic surgery. About 270 adults took part. The idea was that cranberry might stop bacteria from sticking to the catheter, reducing infection risk.
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Early antibiotic treatment may reduce preterm birth risk
Prevention CompletedThis study tested whether giving an antibiotic (clindamycin) to pregnant women with bacterial vaginosis (a common vaginal infection) before 13 weeks of pregnancy could lower the chance of very early preterm birth. Over 3,000 pregnant women took part. The goal was to see if early …
Phase 4 • Sponsor: University Hospital, Lille • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Labour antibiotic may shield newborns from infections
Prevention CompletedThis study tested whether giving mothers a single 2-gram dose of the antibiotic azithromycin during labour could reduce the risk of skin and soft tissue infections in their babies during the first three months of life. Over 2,000 pregnant women in Fiji took part, receiving either…
Phase 3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 26, 2026 14:38 UTC
-
Malawi shifts vaccine strategy to boost herd immunity against pneumonia
Prevention CompletedThis study in Blantyre, Malawi, compares two schedules of the pneumococcal conjugate vaccine (PCV13): the current 3-dose schedule without a booster (3+0) versus a 2-dose schedule with a booster at 9 months (2+1). The goal is to see if the booster reduces carriage of vaccine-type …
Sponsor: University of Liverpool • Aim: Prevention
Last updated Jun 26, 2026 13:52 UTC
-
Can a common antioxidant shield kidneys from leptospirosis?
Symptom relief CompletedResearchers are testing whether oral N-acetylcysteine (NAC) can reduce signs of kidney tubular injury, oxidative stress, and inflammation in adults with non-severe leptospirosis. The trial enrolls 64 adults who have had fever for three to five days and a confirmed Leptospira infe…
Phase 2 • Sponsor: Dr Cipto Mangunkusumo General Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Chilling dental anesthetic may cut root canal pain
Symptom relief CompletedResearchers are testing whether cooling local anesthetic before injecting it into the tooth's pulp reduces pain during root canal treatment. The trial enrolls 40 people with painful, inflamed lower molars who need a root canal. Each participant receives the anesthetic at either c…
Sponsor: Gulf Medical University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Which root canal file leaves less pain? trial puts two systems to the test
Symptom relief CompletedResearchers compare two root canal file systems, ProTaper Gold and ProTaper Ultimate, to see if they differ in how much pain patients feel afterward. The trial enrolls 40 adults with permanent lower molars diagnosed with symptomatic irreversible pulpitis and apical periodontitis.…
Sponsor: Gulf Medical University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Which root canal sealer leaves patients in less pain?
Symptom relief CompletedResearchers compare three sealers used during root canal treatment, Totalfil, NeoSealer, and AH-Plus, to see how much pain patients feel afterward. The study includes 39 people with painful, inflamed lower molars that need a root canal. Each participant receives one of the three …
Sponsor: Gulf Medical University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Which dental filling material keeps molars alive and Pain-Free?
Symptom relief CompletedResearchers compare two materials used in pulpotomy, a procedure that removes inflamed pulp from a tooth and covers the remaining tissue. Adults with deep cavities and signs of pulp inflammation in lower first or second molars receive either BIO MTA+ or Well-Root PT. The study me…
Phase 4 • Sponsor: TC Erciyes University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Calmer Wake-Ups for kids after eye surgery: which anesthesia dose works best?
Symptom relief CompletedThis study tests whether a lower dose (6%) or a higher dose (8%) of sevoflurane gas works better and causes fewer side effects when putting children aged 1 to 6 years to sleep for minor eye surgery. The main goal is to see which dose leads to less agitation and confusion when the…
Sponsor: Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Green tea extract may ease tooth pain after Root-Saving procedure
Symptom relief CompletedThis study looks at whether rinsing with a green tea extract (EGCG) during a tooth-saving procedure (pulpotomy) can lower pain and improve success rates in adults with severe tooth decay. 64 participants with deep cavities will receive one of two rinses and one of two filling mat…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Root canal pain relief: does adding NSAIDs to paracetamol help?
Symptom relief CompletedThis study looked at how well paracetamol alone or combined with different NSAIDs (ibuprofen, mefenamic acid, or diclofenac) controls pain after root canal treatment. 185 adults with severe tooth pain took part. The goal was to see if combining drugs works better than paracetamol…
Phase 2 • Sponsor: University of Khartoum • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Warm fillings may soothe sensitive teeth — a trial puts it to the test
Symptom relief CompletedThis trial tests whether warming up dental filling materials before placement can reduce inflammation inside the tooth and lessen pain after treatment. Thirty adults with deep cavities will receive fillings at different temperatures — one group gets a special flowable composite p…
Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Pill or injection? trial tests which piroxicam method best eases root canal pain
Symptom relief CompletedThis trial compares two ways of giving the anti-inflammatory drug piroxicam to control pain after root canal treatment: a standard oral pill versus an injection into the ligament around the tooth. Adults with a toothache caused by irreversible pulpitis will receive one of the two…
Phase 4 • Sponsor: Pakistan Institute of Medical Sciences • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Chill out tooth pain: cooling inside of tooth during root canal may ease ache
Symptom relief CompletedThis study tests whether using cooled liquid to clean the inside of a tooth during root canal treatment can reduce pain afterward. It includes adults with certain tooth conditions who need a root canal. The approach involves comparing cooled versus room-temperature irrigation to …
Sponsor: Recep Tayyip Erdogan University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Could a simple injection make root canals less painful?
Symptom relief CompletedThis trial tests whether a corticosteroid injection given before root canal treatment can reduce pain and inflammation afterward. One hundred adults with symptomatic pulpitis (tooth nerve inflammation) are randomly assigned to receive either standard root canal treatment alone or…
Sponsor: Istanbul Medipol University Hospital • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New injection aims to smooth cellulite dimples
Symptom relief CompletedThis study tests an investigational drug called CBL-514, given as an injection into areas of cellulite on the thighs. The goal is to see if it can safely reduce the severity of cellulite dimpling. The trial involves women aged 18 to 64 with mild to moderate cellulite. Researchers…
Phase 2 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Pre-Dental painkiller may boost numbing power for root canals
Symptom relief CompletedThis study tests whether taking ibuprofen before a root canal can improve the effectiveness of local anesthesia in people with severe tooth inflammation (irreversible pulpitis). Participants will receive either ibuprofen or a placebo before the procedure, and pain levels will be …
Phase 1 • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Ice or steroid? simple rinse could ease root canal pain
Symptom relief CompletedThis study compares two final rinses inside the tooth after root canal treatment for people with severe tooth pain from irreversible pulpitis. One rinse is a cold saline solution (cryotherapy), the other is a steroid solution (dexamethasone). The goal is to see which better reduc…
Phase 4 • Sponsor: October 6 University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a gel injection smooth away cellulite? new trial investigates
Symptom relief CompletedThis study tests whether ALIDYA, a gel injected into the skin, can improve the appearance of cellulite on the back of the thighs. Thirty women aged 20 to 45 with mild to moderate cellulite received six weekly treatments. Researchers used photos, ultrasound, and other imaging to m…
Sponsor: Medical University of Silesia • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple device make root canals less painful?
Symptom relief CompletedThis trial investigates whether using an electronic apex locator to determine the exact stopping point during root canal treatment can reduce pain afterward. Participants with a single-rooted tooth needing a root canal are randomly assigned to one of three groups: two groups use …
Sponsor: Prof Nazeer Khan • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Patch over pill? new study tests pain relief after root canal
Symptom relief CompletedThis study tested whether pain-relieving skin patches work as well as oral tablets for pain after root canal treatment. 80 adults with tooth pain received either a ketoprofen or fentanyl patch, or an oral medication. They rated their pain over 48 hours. The goal was to see if pat…
Phase 4 • Sponsor: Nims University Rajasthan • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New tool helps women with bladder infections skip unnecessary antibiotics
Symptom relief CompletedThis study tested whether a shared decision-making tool could help women with uncomplicated cystitis (bladder infection) and their doctors decide together about antibiotic use. 169 women aged 18-65 participated. The goal was to see if the tool reduced antibiotic use without harmi…
Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Could a simple pill replace the drill for toothache emergencies?
Symptom relief CompletedThis study compared an oral steroid (prednisolone) to a partial root canal for relieving severe tooth pain from pulpitis. Only 5 adults with a painful lower molar took part. The goal was to see if the pill could reduce pain enough to delay the full root canal by 72 hours, potenti…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Which painkiller works best after a root canal? study pits diclofenac against ibuprofen
Symptom relief CompletedThis study compared two common painkillers—diclofenac sodium and ibuprofen—for managing pain after a root canal. Sixty adults with irreversible pulpitis received one of the two drugs right after treatment, and their pain was tracked for 48 hours. The goal was to see which drug pr…
Phase 4 • Sponsor: Armed Forces Institute of Dentistry, Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New device AVELI tackles cellulite and fibrosis in liposuction patients
Symptom relief CompletedThis study tested a device called AVELI to safely reduce cellulite and fibrous tissue in 130 people undergoing body contouring surgery. Researchers measured safety, patient satisfaction, and appearance improvements over 9 months. The goal was to see if adding AVELI to standard li…
Sponsor: Total Definer Research Group • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New study compares two root canal methods to reduce post-treatment pain
Symptom relief CompletedThis study looked at 146 adults with painful tooth inflammation who needed root canal treatment. It compared two different tools (WaveOne and ProTaper) to see which one leads to less pain after the procedure. Patients rated their pain at several times over a week. The goal is to …
Sponsor: Armed Forces Institute of Dentistry, Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Dentists test three common irrigants to ease root canal pain
Symptom relief CompletedThis study tested three different rinses used during root canal treatment to see which one causes the least pain afterward. Ninety adults with tooth pain took part, and each received one of the rinses: sodium hypochlorite, hydrogen peroxide, or normal saline. Pain levels were mea…
Sponsor: CMH Multan Institute of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New antibiotic shows promise for fast UTI symptom relief in women
Symptom relief CompletedThis completed Phase 3 trial tested the antibiotic gepotidacin in 97 adolescent and adult women with uncomplicated urinary tract infections (UTIs). The goal was to see if symptoms like pain and urgency improved within 24 hours. Researchers measured symptom scores and safety. The …
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Could a simple bandage help sepsis patients? new study explores
Symptom relief CompletedThis study tested whether a whole-body compression bandage could help reduce fluid buildup in ICU patients with severe sepsis or septic shock. 64 patients on mechanical ventilation received the bandage within 12 hours of admission. Researchers tracked daily fluid balance and chec…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Catheter freedom: new study says Day-One removal may be just as safe
Symptom relief CompletedThis study looked at whether women who had surgery for prolapse or incontinence could safely remove their urinary catheter at home one day after surgery, instead of waiting 3-4 days. 128 women who failed a voiding trial before leaving the hospital took part. The main goal was to …
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
No-Needle gadgets take the ouch out of Kids' shots
Symptom relief CompletedThis study tested several non-drug methods—like a textured plastic device called ShotBlocker, a vibrating ice pack (Buzzy), and a skin-tapping technique—to reduce pain from injections in children aged 4 to 6. 120 kids in a pediatric emergency department took part. The goal was to…
Sponsor: Sakarya University • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Can a simple massage help septic shock patients heal faster?
Symptom relief CompletedThis pilot study tested whether manual lymphatic drainage, a gentle massage technique, is safe and feasible for patients recovering from septic shock. Researchers enrolled 24 adults in the ICU and compared those who received the massage plus usual care to those who received usual…
Sponsor: University Hospital Ostrava • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Light therapy may ease root canal pain
Symptom relief CompletedThis study tested whether photodynamic therapy (PDT) — a light-activated disinfection method — can reduce pain after root canal treatment. 95 adults with infected back teeth received either standard cleaning or PDT-enhanced cleaning. Researchers measured pain levels and painkille…
Sponsor: Atlas University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Leg swelling relief: simple therapy shows promise for vein disease
Symptom relief CompletedThis study tested a treatment called Complex Decongestive Therapy (CDT) for people with venous insufficiency, a condition where leg veins struggle to send blood back to the heart. Twenty-one adults received either CDT plus exercises or exercises alone. The goal was to see if CDT …
Sponsor: University of Salamanca • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Tape away cellulite? new study tests kinesio taping on thighs
Symptom relief CompletedThis pilot study tested whether kinesio taping, applied weekly for four weeks, can improve skin structure and reduce stage II cellulite in women aged 18-45 with normal BMI. Researchers compared a group receiving the tape on thighs and buttocks to a no-treatment control group. The…
Sponsor: Klaipedos valstybine kolegija • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Liberia's HIV epidemic under the microscope: major study completed
Knowledge-focused CompletedThis study followed 1,377 people living with HIV in Liberia over three years to track how the disease progresses and affects their health. Researchers collected blood and urine samples, conducted physical exams, and asked about medications and risk behaviors. The goal was to gath…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Speedy bug ID: new tests aim to cut antibiotic guesswork in ICU blood infections
Knowledge-focused CompletedThis study tested whether three new diagnostic tools could help doctors pick the best antibiotic faster for ICU patients with Gram-negative bloodstream infections. Researchers compared standard lab methods to the new tests in 100 patients. The goal was to see if more patients got…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Anthrax secrets revealed: new study tracks infection and vaccine response
Knowledge-focused CompletedThis study follows people who have or had anthrax, those exposed, and healthy vaccinated volunteers to learn how the body fights the disease. Researchers will track symptoms, immune responses, and long-term health for up to 2 years. The goal is to better understand anthrax and im…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Two cheap blood ratios put to the test as sepsis death predictors
Knowledge-focused CompletedSepsis and septic shock cause organ failure and death, and doctors need simple ways to flag the patients most at risk. Researchers at Benha University Hospital followed 60 adults with sepsis or septic shock in a surgical intensive care unit for 28 days. They compared two ratios c…
Sponsor: Benha University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Joint infection study asks: how much does it cost your daily life?
Knowledge-focused CompletedProsthetic joint infections are rare but serious, often causing long hospital stays and lasting disability. Researchers at a French hospital are asking adults with these infections to fill out standard quality-of-life questionnaires during their regular follow-up visits. The stud…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Scientists create controlled whooping cough infection to speed up vaccine research
Knowledge-focused CompletedThis completed phase 1 study tested whether giving healthy adults a controlled dose of whooping cough bacteria via nasal spray can safely cause mild infection. The goal was to establish a human infection model for future vaccine and treatment research. 79 participants aged 18-40 …
Phase 1 • Sponsor: Dalhousie University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Hospital staff TB screening under review: are routine tests necessary?
Knowledge-focused CompletedThis study looks back at records of over 1,000 new hospital workers in Nice, France, who were tested for latent (hidden) tuberculosis infection as part of their hiring process. The goal is to see how many test positive, what factors increase the risk, and whether the screening le…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
HPV infections in transgender people: a hidden health gap gets a closer look
Knowledge-focused CompletedThis observational study measures how often HPV infections and other sexually transmitted infections occur in transgender adults. Researchers will check for HPV at genital, anal, and oral sites, and also look for anal dysplasia, which can be a precursor to cancer. The study inclu…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Stomach acid drugs may skew h. pylori stool test results
Knowledge-focused CompletedThis study looks at whether taking common acid-reducing drugs (proton pump inhibitors, or PPIs) affects the accuracy of a stool DNA test for H. pylori, a stomach bacteria. Researchers will test 25 adults who need PPIs, first while on the drug and then after stopping it for 4 week…
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists use clean ticks to sniff out hidden lyme infection
Knowledge-focused CompletedThis study tested whether clean, lab-bred ticks could find leftover Lyme bacteria in people who had been treated with antibiotics. 45 participants, including those with recent or past Lyme disease and healthy volunteers, had ticks placed on their skin for a few days. The goal was…
Early phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists probe Drug-Induced sunburn reactions
Knowledge-focused CompletedThis study looks at why some medications, like the antifungal voriconazole, can cause extreme sensitivity to sunlight, leading to severe sunburn-like reactions. Researchers will measure gene activity in skin samples from 62 participants, including healthy volunteers and patients …
Phase 1 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Which TB test works best for HIV patients? new study aims to find out
Knowledge-focused CompletedThis study looked at 200 people living with HIV in Liberia to compare two tests for latent tuberculosis (TB) infection: a blood test (IGRA) and a skin test (TST). The goal was to see which test works better in this population. Participants had a skin test and their results were c…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists compare sputum collection methods to improve diagnosis of lung infection
Knowledge-focused CompletedThis study looked at different ways to collect sputum (phlegm) from people with a lung infection called nontuberculous mycobacterial (NTM) infection. The goal was to see which method gives the best samples for diagnosing and understanding the infection. Participants provided thro…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
TB drug dosing under the microscope: could this lead to shorter, safer treatment?
Knowledge-focused CompletedThis completed Phase 3 study measured how high doses of the tuberculosis drugs rifapentine and moxifloxacin move through the body in 53 adults with TB. Participants gave multiple blood samples to track drug levels. The goal was to understand the best doses to kill TB bacteria whi…
Phase 3 • Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can weekly tests pinpoint when STIs are truly gone?
Knowledge-focused CompletedThis study follows 140 adults who have been treated for uncomplicated chlamydia or gonorrhea infections. Participants will have weekly swabs or urine tests to check when the bacteria's genetic material (RNA) disappears from the body, up to 4 weeks after starting treatment. The go…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can a new score better predict ICU deaths? turkish study aims to find out
Knowledge-focused CompletedThis study will check if a new scoring system called SOFA-2 can better predict which ICU patients are likely to die within 30 days, compared to the current standard. Researchers will also measure how common sepsis and septic shock are in Turkish intensive care units. About 2,500 …
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Hotspot vs clinic: which TB hunt saves more lives?
Knowledge-focused CompletedThis study compares two strategies for finding undiagnosed tuberculosis (TB) in peri-urban Uganda. One strategy sets up screening at a large health clinic, while the other sends mobile screening teams into local hotspots where TB is thought to be most common. Researchers will tra…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can a new patient cohort unlock the secrets of TB treatment success?
Knowledge-focused CompletedThis pilot study aims to test the feasibility of creating a large-scale cohort of tuberculosis (TB) patients in northern Paris, an area with high TB rates. Researchers will collect blood samples and clinical data from 30 participants over the course of their treatment to understa…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can High-Dose amoxicillin be made safer?
Knowledge-focused CompletedThis study looks at patients receiving high-dose intravenous amoxicillin for serious bacterial infections. Researchers will measure drug levels in the blood during the first week to see how much they vary between patients and within the same patient. They will also check for side…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Can company leaders help curb TB in High-Risk workplaces?
Knowledge-focused CompletedThis study surveys senior managers at companies in Zambia with silica dust exposure to assess their knowledge, attitudes, and practices regarding tuberculosis. Since these leaders shape workplace policies, their understanding is key to protecting workers. The findings could highl…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could leptospirosis leave lasting damage? a new study investigates
Knowledge-focused CompletedThis study looks at whether people who had leptospirosis, a bacterial infection spread by animals, may have health problems that last for years after the initial illness. Researchers in Reunion will follow about 200 patients who were previously hospitalized with the disease, chec…
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could your gut bacteria shape your mood after cancer surgery?
Knowledge-focused CompletedThis study looks at whether having certain E. coli bacteria in the colon after colorectal cancer surgery is linked to anxiety or depression. Researchers will compare psychiatric symptoms and diagnoses between patients who carry the bacteria and those who do not. The goal is to be…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Brazil launches massive leprosy hunt: can active screening catch hidden cases?
Knowledge-focused CompletedThis trial tests whether actively searching for leprosy cases in communities finds more people with the disease than waiting for them to come to clinics. Researchers will raise awareness, train healthcare workers, and use questionnaires and rapid tests in high-risk areas. About 1…
Sponsor: Hospital Alemão Oswaldo Cruz • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Blood clot score may predict organ damage in septic shock
Knowledge-focused CompletedSeptic shock is a life-threatening condition where infection leads to dangerously low blood pressure. Many patients also develop disseminated intravascular coagulation (DIC), a disorder that causes abnormal blood clotting throughout the body. This study will follow 60 adults in t…
Sponsor: Sanjay Gandhi Postgraduate Institute of Medical Sciences • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Are adults in beijing still protected against tetanus? a study investigates
Knowledge-focused CompletedThis observational study aims to measure tetanus antibody levels in healthy adults living in Beijing, China. Researchers will analyze how antibody protection varies across different age groups and whether vaccination history predicts current immunity. Participants provide a singl…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Blood gas clues could reveal hidden danger in sepsis patients
Knowledge-focused CompletedThis study looks at whether measuring oxygen and carbon dioxide differences in the blood can help predict which sepsis patients in the ICU are at highest risk of dying within 28 days. Researchers will track these levels in 88 intubated patients with sepsis who have a central veno…
Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Kidney function may change TB drug dosing
Knowledge-focused CompletedThis study looked at how the tuberculosis drug pretomanid is processed in people with different levels of kidney function. Twelve participants received a single 200 mg dose, and researchers compared drug levels in those with kidney impairment to healthy matched controls. The goal…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Your DNA may determine if the Dentist's needle works
Knowledge-focused CompletedThis study looks at whether certain genetic variations (in COMT, MAOA, and SLC6A4) influence how well a standard dental numbing injection works for people with a painful tooth condition called irreversible pulpitis. Participants received a numbing shot and had their pain levels m…
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Could a common antibiotic replace stronger ones for severe pneumonia?
Knowledge-focused CompletedThis completed study looked at 104 adults in the ICU with severe pneumonia caused by three common bacteria. Researchers checked whether the bacteria were sensitive to amoxicillin/clavulanic acid (AMC) or to third-generation cephalosporins (3GC), which are standard treatments. The…
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New study aims to personalize septic shock treatment with biomarkers
Knowledge-focused CompletedThis completed pilot study tested whether two biomarkers (renin and DPP3) can predict how well patients with septic shock respond to angiotensin II, a drug that raises blood pressure. Forty adults with persistent low blood pressure despite standard treatment were randomly assigne…
Phase 4 • Sponsor: University of New Mexico • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Tracking superbugs from mother to baby: a chicago study
Knowledge-focused CompletedThis study looks at how drug-resistant bacteria, specifically ESBL-producing E. coli, are passed from mothers to their newborns during vaginal birth or scheduled C-sections. Researchers will test stool samples from 200 healthy mothers and their babies at a Chicago hospital to see…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Rare botulism cases reviewed to improve ICU care
Knowledge-focused CompletedThis study reviews the medical records of people who were hospitalized in French intensive care units (ICUs) for severe botulism poisoning. Botulism is a rare but serious illness caused by a toxin that can paralyze muscles. The goal is to describe what happened to these patients,…
Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Nose drops of pneumonia bacteria could pave way for better vaccines
Knowledge-focused CompletedThis study investigates how a specific strain of pneumococcus bacteria (serotype 3) colonizes the nose of healthy adults. Researchers will give volunteers nose drops containing the bacteria to see what dose leads to colonization and how long the bacteria stay before the immune sy…
Sponsor: Liverpool School of Tropical Medicine • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Kidney function may change how antibiotic levornidazole acts in the body
Knowledge-focused CompletedThis study looks at how a single dose of the antibiotic levornidazole is processed by the body in people with moderate or severe kidney impairment compared to healthy volunteers. Researchers will measure drug levels in the blood and urine, and monitor safety. The goal is to under…
Phase 1 • Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
AI predicts dental numbing success in painful tooth condition
Knowledge-focused CompletedThis study looks at whether computer models can predict if local anesthetic (numbing) will work for people with a painful tooth condition called symptomatic irreversible pulpitis. Researchers analyzed records from 4,390 adult patients to compare three different machine learning a…
Sponsor: Jamia Millia Islamia • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Emergency room study aims to improve diagnosis of septic arthritis
Knowledge-focused CompletedThis study examined 750 emergency patients with joint pain to find out which germs cause septic arthritis. Researchers compared standard lab cultures with a new PCR test to see which works better. The goal is to help doctors diagnose joint infections more quickly and accurately.
Sponsor: Olive View-UCLA Education & Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Study links NSAIDs to severe bacterial infections
Knowledge-focused CompletedThis study looked at 335 adults hospitalized with bacterial infections to see if taking NSAIDs (like ibuprofen) before admission made their infections more severe. Researchers compared those with complicated infections (abscesses, needing surgery) to those with simpler infections…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Study tracks pneumococcal infections in adults to sharpen vaccine strategies
Knowledge-focused CompletedThis completed study monitored 1560 adults hospitalized with invasive pneumococcal infections (excluding meningitis) across France. Researchers collected information on infection severity, risk factors, and bacterial serotypes to understand how these infections occur and how vacc…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New algorithm may simplify heart checks in septic shock patients
Knowledge-focused CompletedThis study tested whether simpler ultrasound measurements can accurately predict left ventricular function in patients with septic shock. Researchers enrolled 80 patients and compared standard heart function tests (LVEF and GLS) with easier-to-collect parameters like mitral annul…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Mapping the hidden germ: pneumococcus in healthy kids
Knowledge-focused CompletedThis study looks at how common pneumococcus bacteria are in the noses and throats of healthy Vietnamese children aged 6 months to 5 years. Researchers will take a simple swab and interview parents about factors like vaccination history, antibiotic use, and living environment. The…
Sponsor: Tam Anh Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Simple bedside check may predict who needs emergency treatment for sepsis
Knowledge-focused CompletedThis study looked at 526 adults with sepsis who had normal blood pressure to see if a simple measure called the diastolic shock index (DSI) and a blood test for lactate could predict which patients would need medication to support their blood pressure within 6 hours. Researchers …
Sponsor: Hospital H+ Queretaro • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hospital data reveals clues about pneumonia relapses
Knowledge-focused CompletedThis completed study reviewed medical records of 203 adults hospitalized with Haemophilus influenzae pneumonia across 13 hospitals. Researchers aimed to find factors linked to early relapse (within 90 days) and severe outcomes like intensive care or death. By analyzing patient da…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
UTI superbugs: study reveals resistance patterns in uganda
Knowledge-focused CompletedThis completed study looked at antibiotic resistance in bacteria causing urinary tract infections (UTIs) in Uganda. Researchers compared resistance patterns in patients who sought care at community drug shops versus hospitals. By studying 890 participants, they aim to understand …
Sponsor: St George's, University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to help detect sepsis in newborns faster
Knowledge-focused CompletedThis study looked at 58 full-term newborns with suspected early-onset sepsis to find early clinical signs that could help doctors tell if a bacterial infection is present. Researchers reviewed medical records from 2013 at a single hospital. The goal was to improve diagnosis and a…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can ultrasound help doctors give the right amount of fluids in septic shock?
Knowledge-focused CompletedThis study tested whether a specific ultrasound-based algorithm could help doctors better manage fluids in patients with septic shock. The trial involved 136 intensive care patients and compared the algorithm to standard care over the first 4 days. The goal was to see if the algo…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New blood marker may help spot deadliest sepsis cases
Knowledge-focused CompletedThis study looked at whether measuring hepcidin, a hormone that controls iron levels, in the blood of 114 patients with severe sepsis or septic shock could predict who would die within 28 days. Researchers also tracked deaths at 90 days and infections acquired in the hospital. Th…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Cancer patients face more treatment side effects from rare lung infections
Knowledge-focused CompletedThis study examined 41 patients treated for non-tuberculous mycobacteria (NTM) infections, comparing those with and without cancer. The goal was to count side effects from NTM treatment in each group to understand why cancer patients often stop therapy. Researchers hope this will…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Meth reduction may lower STI risk, small study suggests
Knowledge-focused CompletedThis completed study looked at 59 men who have sex with men and use methamphetamine. Researchers used a program that gives rewards for drug-free urine samples to help them cut back. They measured inflammation in the rectum and tracked STI/HIV risk behaviors over 8 weeks. The goal…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
TB drug dosing under the microscope: could standard doses be off?
Knowledge-focused CompletedThis study examined whether the standard dose of isoniazid, a key tuberculosis drug, is right for all adults. Researchers measured drug levels in 112 patients to see if some were getting too much or too little. The goal was to understand how individual differences in drug process…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Massive ethiopian trial tests hygiene vs. antibiotics for blinding eye disease
Knowledge-focused CompletedThis large study in rural Ethiopia looked at whether providing clean water, sanitation, and face-washing education can reduce trachoma infections in communities that have already received many rounds of antibiotics. Over 47,000 people from 40 communities took part. The goal is to…
Phase 3 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Healthy volunteers help uncover drug safety secrets
Knowledge-focused CompletedThis study looked at how a new drug called OPC-167832 is processed by the liver when taken with other common medicines. Twenty-four healthy adults took part to see if certain drugs slow down or speed up the breakdown of OPC-167832. The goal was to gather safety information, not t…
Phase 1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Are cirrhosis patients getting the shots they need? french study finds out
Knowledge-focused CompletedThis study looked at how many people with cirrhosis in French general hospitals were vaccinated against diseases like hepatitis, flu, and COVID-19. Researchers surveyed 742 patients to see if they were up to date on their shots. The goal was to find gaps in vaccination coverage s…
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Gum fluid test could spot tooth nerve inflammation
Knowledge-focused CompletedThis study looked at 36 adults with painful tooth nerve inflammation (irreversible pulpitis) to see if biological markers in gum fluid match symptoms. Researchers collected gum fluid samples before and after root canal treatment and measured pain levels. The goal was to find a li…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
New test may help doctors pick the right antibiotic for diabetic foot wounds
Knowledge-focused CompletedThis study looked at a new lab test called Antibiofilmogramme for people with diabetic foot infections caused by Staph bacteria. The goal was to see if the test could help doctors choose antibiotics that work better. 33 adults took part, and the study did not change their regular…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Common diabetes drug may boost survival in septic shock
Knowledge-focused CompletedThis study looked back at medical records of 2,740 adults with type 2 diabetes who were admitted to the ICU for septic shock, a life-threatening infection. Researchers wanted to see if those who were already taking metformin (a standard diabetes pill) before getting sick had a lo…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Gut leaks in septic shock: a closer look at hidden infections
Knowledge-focused CompletedThis study looked at 60 intensive care patients with septic shock to see if their intestines become leaky, allowing bacteria to enter the blood. Researchers measured specific markers in the blood over a week to track gut damage and changes in gut bacteria. The goal was to better …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Mobile TB testing vans could catch hidden cases in slums
Knowledge-focused CompletedThis study tested whether bringing a portable TB test (Gene Xpert) directly to people in crowded communities helps find and treat more TB cases than the usual method of waiting for people to visit a clinic. Over 3,500 adults in South Africa took part. The goal was to see if this …
Sponsor: University of Cape Town • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Ultrasound at the bedside: a game changer for septic shock?
Knowledge-focused CompletedThis study looked at whether using a portable ultrasound machine at the patient's bedside (called POCUS) helps doctors better treat people with septic shock in the intensive care unit. Researchers compared two groups of patients: one treated before POCUS was widely used and one a…
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Antibiotic side effects under the microscope in bone infection study
Knowledge-focused CompletedThis completed study followed 73 adults with bone or joint infections who needed antibiotics for at least 6 weeks. Researchers tracked how often side effects occurred, how severe they were, and whether they affected quality of life. The goal was to understand why some patients st…
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Superbug surveillance: 14,000 patients swabbed to map resistance
Knowledge-focused CompletedThis completed study monitored over 14,000 hospital patients for multidrug-resistant organisms (MDROs) by taking rectal swabs and tracking bloodstream infections. Researchers analyzed the bacteria's genetics and how they resist antibiotics, aiming to understand how resistance eme…
Sponsor: University of Luebeck • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Harmless virus levels may predict transplant complications
Knowledge-focused CompletedThis study looked at 172 kidney transplant recipients who were on stable anti-rejection medication for at least 3 months. Researchers measured levels of a common, harmless virus (Torque Teno Virus) in their blood to see if it could predict serious infections or organ rejection. T…
Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
NICU antibiotic study questions routine use for tiniest babies
Knowledge-focused CompletedThis study looked at whether giving antibiotics early to extremely low birthweight babies (born before 31 weeks) might cause more harm than good. Researchers compared babies who got standard antibiotics to those who got a placebo. The goal was to see if early antibiotics increase…
Phase 4 • Sponsor: Michael Morowitz • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Yogurt study probes how friendly bacteria survive the gut
Knowledge-focused CompletedThis study looked at whether eating fermented dairy products with three types of Bifidobacterium (with or without prebiotic fibers) for 28 days changes the variety of gut bacteria in healthy people aged 45 to 60. 182 participants ate either a test yogurt or a regular yogurt. The …
Sponsor: Danone Global Research & Innovation Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Are hidden immune defects causing your recurring infections? new study investigates.
Knowledge-focused CompletedThis study looked for hidden immune system problems in adults who get frequent or severe bacterial infections, like pneumonia or meningitis. Researchers screened 120 adults aged 18-65 to see how many had an undiagnosed primary immunodeficiency. The goal was to find out if these c…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New alert system aims to cut unnecessary antibiotics in pneumonia patients
Knowledge-focused CompletedThis study tested whether electronic alerts and structured messages from an antibiotic stewardship team could reduce antibiotic use in hospitalized patients with suspected pneumonia. 107 adults were enrolled, and those with test results suggesting viral infection were randomly as…
Sponsor: Jonathan Baghdadi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New rapid test could help ICU doctors pick the right antibiotic faster
Knowledge-focused CompletedThis study tested whether a rapid test called Unyvero could help doctors choose the right antibiotic sooner for patients with pneumonia who are on breathing machines in the ICU. The test looks for bacteria and their resistance genes in just a few hours, compared to standard lab c…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Scientists seek perfect antibiotic dose for young burn victims
Knowledge-focused CompletedThis study aimed to find the best dose of the antibiotic ceftazidime for critically ill children with severe burns. Researchers took blood samples from 3 children to measure how the drug moves through the body. The goal was to learn how to personalize dosing to improve treatment …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Can we shorten antibiotic treatment for cellulitis? new study seeks answers
Knowledge-focused CompletedCellulitis is a painful skin infection that often requires antibiotics, but the ideal treatment length is unknown. This study followed 230 adults hospitalized with cellulitis to identify factors that predict a good recovery, such as medical history and early response to treatment…
Sponsor: University of Sussex • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Hidden inflammation lingers after urethritis, new study suggests
Knowledge-focused CompletedThis study checks if men who had a treated urethritis infection still have signs of long-term inflammation and cell damage in their genital tract. Researchers measured a protein called elastase and markers of oxidative stress in semen 6 and 12 months after treatment. They compare…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
ICU antibiotic study reveals resistance risks
Knowledge-focused CompletedThis study examined whether giving ICU patients the same antibiotic they had before, versus a different one, affects the development of drug-resistant bacteria. Researchers looked at 197 adults with Gram-negative infections. The goal was to understand how antibiotic choice impact…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Large study aims to uncover who is most at risk from listeria infection
Knowledge-focused CompletedThis study looked at over 2,100 people with listeriosis, a serious foodborne infection that can cause blood infections, brain infections, and pregnancy complications. Researchers collected data to find out which clinical, biological, and genetic factors make someone more likely t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Antibiotic drip showdown: continuous vs. intermittent for bone infections
Knowledge-focused CompletedThis study looked at two different ways of giving the antibiotic cloxacillin to treat bone and joint infections caused by Staphylococcus aureus bacteria. Twelve patients received the drug both as a steady drip (continuous infusion) and as short doses (intermittent infusion) to se…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Root canal pain relief may depend on your DNA
Knowledge-focused CompletedThis study looked at whether a specific gene variation (SCN9A rs6746030) affects the success of numbing injections for root canal treatment. Researchers compared 200 patients with irreversible pulpitis who either had successful or failed anesthesia. By analyzing DNA from cheek sw…
Sponsor: Jamia Millia Islamia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
French study tracks unusual rise in child mycoplasma infections
Knowledge-focused CompletedThis study looked at 1,145 children under 18 who were hospitalized in France for mycoplasma infections between June and November 2023. Researchers collected medical data to better understand the infection and improve hospital care. The goal was to describe the infection's feature…
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Heart pumping problems linked to worse outcomes in septic shock
Knowledge-focused CompletedThis study looked at 440 ICU patients with septic shock to see how their heart's pumping and relaxation abilities affected survival. Researchers measured heart function using ultrasound and tracked fluid balance. The goal was to better understand which heart problems are linked t…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Scientists deliberately give volunteers strep throat to speed up vaccine development
Knowledge-focused CompletedThis completed early-phase study tested a new way to study Strep A bacteria, which causes strep throat and can lead to serious heart disease. Researchers safely exposed 40 healthy adults aged 18-40 to a specific strain of Strep A under controlled conditions. The goal was to see h…
Early phase 1 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
AI model aims to predict ICU deaths from superbug blood infections
Knowledge-focused CompletedThis study looked at 197 ICU patients with bloodstream infections caused by carbapenem-resistant bacteria (superbugs). Researchers used machine learning to analyze patient data and predict which patients were at higher risk of dying. The goal is to create a tool that helps doctor…
Sponsor: Kocaeli University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Scientists hunt superbug in water and people to stop its spread
Knowledge-focused CompletedThis study aimed to create a smart surveillance strategy for carbapenem-resistant Pseudomonas aeruginosa (CRPA), a superbug that causes hard-to-treat infections in hospitals. Researchers collected samples from over 2,100 healthy people, patients, and hospital environments in the …
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Blood pressure tweaks may predict kidney outcomes in septic shock
Knowledge-focused CompletedThis study looked at 80 adults with septic shock to see if raising blood pressure from 65 mmHg to 85 mmHg improves kidney function. Researchers used ultrasound to measure kidney blood flow and tracked changes in kidney injury stages. The goal was to find out if a higher blood pre…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New tool could spot tough pneumonia early
Knowledge-focused CompletedThis study created and tested a risk score called RESPIRE to predict whether a patient's pneumonia is caused by multidrug-resistant bacteria. Researchers looked at data from 300 adults with community-acquired pneumonia in the emergency department. The goal is to help doctors quic…
Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
AI boosts doctor accuracy for rare skin diseases in new study
Knowledge-focused CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors diagnose rare and tricky skin conditions like generalized pustular psoriasis (GPP). Fifteen doctors, including both general practitioners and dermatologists, looked at 100 skin images. They first ga…
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
What predicts survival in severe kidney infections? new study digs into the data
Knowledge-focused CompletedThis study reviewed 575 adults admitted to intensive care for a severe kidney infection called acute obstructive pyelonephritis. Researchers aimed to identify factors that lead to poor outcomes such as death or lasting kidney damage. The goal is to better understand which patient…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Blood test may predict sepsis survival
Knowledge-focused CompletedThis study looked at whether measuring immature platelets in the blood can help predict how septic shock patients will fare. Researchers followed 196 intensive care patients and checked if the immature platelet fraction at admission was linked to death or organ failure at 28 days…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Whooping cough vaccine safety under the microscope in thailand
Knowledge-focused CompletedThis completed study looked at the safety of the VacPertagen whooping cough vaccine in over 5,400 people in Thailand, including pregnant women and their newborns. Healthcare workers reported any side effects after vaccination using standard forms. The goal was to catch any unexpe…
Sponsor: BioNet-Asia Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Can a protein fluid help septic shock patients? small study tests the waters
Knowledge-focused CompletedThis study looked at whether giving a concentrated protein fluid called albumin, along with standard fluids, is possible in patients with septic shock (a life-threatening infection causing very low blood pressure). 47 adults took part to see if doctors could recruit enough patien…
Phase 2/3 • Sponsor: Manchester University NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Prison TB study tests shorter prevention course
Knowledge-focused CompletedThis study looked at ways to prevent tuberculosis (TB) in Malaysian prisoners, many of whom also had HIV, opioid addiction, or hepatitis. Researchers compared a standard 40-week TB prevention treatment with a shorter 12-week option. The goal was to see which approach worked bette…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Protein clue may explain dangerous fluid overload in sepsis
Knowledge-focused CompletedThis study looked at 103 adults with septic shock to see if a protein called VEGF-A is linked to how much extra fluid their bodies hold. Septic shock causes blood vessels to leak, leading to dangerous fluid buildup. Researchers measured VEGF-A levels and fluid balance to better u…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Global ICU fluid study reveals how doctors manage critical illness
Knowledge-focused CompletedThis study observed how fluids are given to nearly 5,000 critically ill patients in intensive care units (ICUs) worldwide. The goal was to describe current practices for fluid challenges (boluses) and maintenance fluids, and to see if different approaches are linked to patient ou…
Sponsor: Humanitas Clinical and Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Scientists probe protein link to muscle wasting in sepsis
Knowledge-focused CompletedThis completed study looked at 52 adults with septic shock to see if a protein called PTP1B and gut barrier changes are linked to muscle loss. Researchers took blood samples and used ultrasound to measure muscle. The goal was to gather knowledge, not to test a treatment.
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
TB cases sought in COVID-19 trial volunteers
Knowledge-focused CompletedThis completed study looked for tuberculosis (TB) cases in 5,694 people who had already finished a COVID-19 vaccine trial. Participants had physical exams, blood tests, and tongue swabs to find TB and study related biomarkers. The goal was to understand how common TB is in this g…
Sponsor: COVID-19 Prevention Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Gut health under the microscope: new study targets hidden danger in ICU blood cancer patients
Knowledge-focused CompletedThis completed study looked at how common gut inflammation and leaky gut are in 80 adults with blood cancer who were in intensive care for sepsis or septic shock. Researchers measured two markers—calprotectin in stool and zonulin in blood—to better understand intestinal dysfuncti…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Colombian pneumonia study reveals key infection patterns
Knowledge-focused CompletedThis study looked at 688 adults hospitalized with pneumonia in 11 hospitals in Colombia to find out how many cases were caused by pneumococcal bacteria. Researchers also identified which bacterial strains were most common and whether current vaccines cover them. The goal is to he…
Sponsor: Universidad de la Sabana • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Could a tailored antibiotic dose save more kids in the ICU?
Knowledge-focused CompletedThis study tested whether giving a personalized dose of the antibiotic vancomycin to critically ill children in the ICU leads to better results than the standard approach. Researchers enrolled 314 children and compared how many reached the target drug level in their blood. The go…
Phase 4 • Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Diabetes may impact dental pulp treatment success
Knowledge-focused CompletedThis study examined whether type 2 diabetes influences how well a dental procedure called pulpotomy works in adults. Researchers compared 70 diabetic and non-diabetic patients who had a molar treated for irreversible pulpitis. They checked the tooth's health, symptoms, and X-ray …
Sponsor: Al-Azhar University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Whooping cough vaccine in pregnancy: new study looks at how antibodies pass to babies
Knowledge-focused CompletedThis completed study looked at 200 women and their infants to understand how the whooping cough vaccine given during pregnancy affects the baby's immune protection. Researchers measured antibody levels in mothers and in umbilical cord blood at birth, as well as in infants after t…
Phase 4 • Sponsor: Centre Hospitalier Universitaire Saint Pierre • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Can better nutrition and cheap worm treatment stop TB?
Knowledge-focused CompletedThis study looked at why some people infected with TB bacteria get sick while others don't. Researchers in India studied 120 household contacts of TB patients, comparing those who were malnourished or had parasitic worms. They provided food and deworming medication to see how the…
Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
COVID-19 organ damage: what happens inside the ICU?
Knowledge-focused CompletedThis study looked at 380 adults in the intensive care unit with suspected or confirmed COVID-19. Researchers tracked organ problems like kidney injury and lung failure, and measured survival rates at 30 days and one year. The goal was to learn how COVID-19 causes organ damage, no…
Sponsor: Uppsala University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New antibiotic TQD3524 tested in kidney patients
Knowledge-focused CompletedThis early-stage study tested a single dose of the antibiotic TQD3524 in 48 people with varying degrees of kidney function. The goal was to see how the drug moves through the body and is removed, especially by the kidneys, and to check for any safety issues. The study did not aim…
Phase 1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Scientists probe the chemistry of tooth pain and stress
Knowledge-focused CompletedThis completed study looked at 72 adults to see how certain chemicals (Substance P and CGRP) in saliva and tooth pulp relate to dental pain, inflammation, and stress. Participants provided saliva samples and had pulp tissue collected during routine root canal treatment. The goal …
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Liver study tracks antibiotic levels in Fluid-Filled bellies
Knowledge-focused CompletedThis study looked at how the antibiotic ceftriaxone moves through the blood and belly fluid in 20 people with severe liver disease and fluid buildup (ascites). Researchers collected leftover blood and fluid samples to measure drug levels. The goal was to better understand dosing …
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Healthy volunteers needed to donate stool for gut research
Knowledge-focused CompletedThis study collected stool samples from 110 healthy adults aged 18-60 to help Danone advance its research on digestive health. Participants had to have regular bowel movements and be in good health. No treatment or medication was given; the goal was simply to gather enough usable…
Sponsor: Danone Global Research & Innovation Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Could a common stomach bug raise your heart disease risk?
Knowledge-focused CompletedThis study looked at 300 people to see if a common stomach infection, H. pylori, is linked to unhealthy blood fat levels that can lead to heart disease. Researchers measured triglycerides and 'good' cholesterol to calculate a heart risk score. The goal is to understand if treatin…
Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Staph bacteria may worsen eczema and trigger dangerous infections
Knowledge-focused CompletedThis study looked at how staphylococcus bacteria on the skin affect inflammation and immune responses in people with moderate to severe atopic dermatitis (eczema). Researchers took skin biopsies and blood samples from 41 adults to measure bacterial toxins and immune cell activity…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Scientists hunt for bacterial toxins behind life-threatening infections
Knowledge-focused CompletedThis study looked at 82 adults infected with Staphylococcus lugdunensis bacteria to find which toxins (harmful substances) the bacteria produce that lead to serious illnesses like blood infections or heart valve infections. Researchers compared samples from patients with differen…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Scientists probe hidden fluid to unlock septic shock mysteries
Knowledge-focused CompletedThis study looked at the fluid between cells (interstitial fluid) in 26 intensive care patients with septic or non-septic shock. Researchers aimed to understand how this fluid changes during severe infections, which could help explain why swelling occurs and how to better manage …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Bacteria's secret hideout: inside bone infection cells
Knowledge-focused CompletedThis study examined tissue samples from 50 patients with staphylococcal bone and joint infections to see if bacteria can hide inside human cells. Researchers used special staining to detect intracellular staphylococci and identify which cell types they occupy. The goal was to bet…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Can your immune system predict a c. diff relapse?
Knowledge-focused CompletedThis study looked at how the immune system responds to Clostridium difficile infection in hospitalized patients. Researchers took blood samples every two days to measure immune markers. The goal was to find out why some patients have repeat infections. The study involved 56 parti…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Blood tests could predict infections in ICU patients
Knowledge-focused CompletedThis completed study looked at how the immune system is weakened after septic shock, severe trauma, burns, or major surgery. Researchers took blood samples from 552 patients and healthy volunteers to measure immune function. The goal was to find better ways to predict and manage …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New antibiotic cocktail takes first step in human safety trial
Knowledge-focused CompletedThis early-stage trial tested the safety and drug interactions of an experimental oral antibiotic combination (QPX7831 plus ceftibuten) in 53 healthy adults. The goal was to see how the body processes the drugs and whether they cause side effects. Results will help decide safe do…
Phase 1 • Sponsor: Qpex Biopharma, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Tiny blood cells may hold key to septic shock damage
Knowledge-focused CompletedThis study looked at how platelets (small blood cells that help with clotting) become activated in people with septic shock, a life-threatening infection that causes organ failure. Researchers measured specific markers on platelets and platelet-white blood cell clumps in 27 patie…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Can less fluid be better for septic shock patients?
Knowledge-focused CompletedThis study tested whether carefully limiting fluids given for non-emergency reasons (like nutrition or drug dilution) could reduce fluid overload in intensive care patients with septic shock. 50 patients were randomly assigned to either the standard approach or a restrictive flui…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
How do antifungals behave in septic shock? small study aims to find out
Knowledge-focused CompletedThis completed Phase 4 study looked at how the body processes echinocandin antifungal drugs (caspofungin or micafungin) in 24 adults with septic shock caused by peritonitis. Researchers measured drug levels in the blood to understand clearance, distribution, and concentration. Th…
Phase 4 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Tiny study checks antibiotic levels in lung infection fluid
Knowledge-focused CompletedThis completed study looked at how the antibiotics amoxicillin and clavulanic acid get into the infected fluid around the lungs in people with pleural infections. Eleven adults with complicated infections had chest tubes placed and received the antibiotics. Researchers measured a…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Tiny camera peers into blood vessels to fight sepsis
Knowledge-focused CompletedThis study tested a handheld microscope to look at tiny blood vessels in 68 adults with sepsis or septic shock. The goal was to understand how these vessels break down during severe infection. The findings may help doctors design better treatments in the future.
Sponsor: Denver Health and Hospital Authority • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Pharmacist intervention may boost pneumococcal shots in hospital patients
Knowledge-focused CompletedThis study looked at whether a clinical pharmacist could help increase pneumococcal vaccination rates in patients at high risk for infection when they leave the hospital. Researchers tracked how many vaccine prescriptions were given to 167 at-risk adults. The goal was to see if t…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Pregnancy drug study aims to Fine-Tune HIV and TB treatment
Knowledge-focused CompletedThis study looked at how HIV and tuberculosis (TB) medications are processed in the bodies of pregnant women and their newborns. Researchers measured drug levels in blood and vaginal fluids to see if dosing needs to change during pregnancy and after birth. Over 1,500 women took p…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Tooth inflammation markers may predict treatment success
Knowledge-focused CompletedThis study looked at 40 people with tooth inflammation (reversible or irreversible pulpitis) to see if certain immune markers in the blood (IL-8 and IL-10) could predict how well a tooth-saving treatment (vital pulp therapy) works. Participants received the therapy, and researche…
Sponsor: Mansoura University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New heart imaging study seeks clues in septic shock survival
Knowledge-focused CompletedThis study looked at 50 adults with septic shock to see how a sensitive heart ultrasound technique, called strain echocardiography, can track heart function changes. The goal was to understand if these measurements can help predict patient outcomes. The research did not test a tr…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Less gas, same safety: new anesthesia method cuts drug use in kidney stone surgery
Knowledge-focused CompletedThis study tested two ways of giving anesthesia gas (sevoflurane) during kidney stone surgery. One method used a very low gas flow (minimal-flow), the other a slightly higher flow (low-flow). In 62 adults, the minimal-flow approach used less anesthesia drug while keeping patients…
Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Do Kids' immune systems crash like Adults' after severe infection? new study investigates
Knowledge-focused CompletedThis study looked at whether children with severe infectious shock develop immune suppression, similar to what is seen in adults. Researchers measured immune markers in 105 children admitted to intensive care and compared them to healthy children having surgery. The goal was to u…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Phone call checklists boost care for blood infection patients
Knowledge-focused CompletedThis study tested whether having a study team call doctors with a checklist could improve how they manage patients with Staphylococcus aureus bloodstream infections. The calls reminded doctors of key steps like follow-up blood cultures, proper antibiotics, and imaging tests. The …
Sponsor: University Medicine Greifswald • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Food as medicine: can nutrition boost TB treatment success?
Knowledge-focused CompletedThis study looked at whether providing nutritional support to people being treated for tuberculosis (TB) improves their outcomes. Researchers compared TB patients in Benin, who receive food baskets and meals, to similar patients in Togo, who do not get systematic nutritional supp…
Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
New blood score could predict septic shock survival
Knowledge-focused CompletedThis study tested a new scoring system that uses routine blood tests to predict the risk of death within one month for patients in intensive care with septic shock. Researchers looked at 780 patients to see how well the score works. The goal is to help doctors make faster, better…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Antibiotic use in kids linked to superbug carriage?
Knowledge-focused CompletedThis completed study tracked 581 hospitalized children aged 1-16 to see how antibiotic treatment affects the development of MRSA in the nose. Researchers compared children who received antibiotics to those who did not. The goal is to understand how antibiotic use drives antimicro…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Timing is everything: fluid challenge evaluation in septic shock
Knowledge-focused CompletedThis study looked at 145 patients with septic shock to see if the time when doctors check if a fluid bolus worked changes the results. Patients received 500 ml of fluid over 10 minutes. The study found that some patients who seemed to respond right away were no longer responding …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Hidden gut infections may sabotage TB recovery, study suggests
Knowledge-focused CompletedThis completed study looked at 141 people being treated for tuberculosis (TB) to see if intestinal parasites or poor nutrition made their recovery harder. Researchers checked stool samples for parasites and measured weight gain and treatment success. Some participants received nu…
Sponsor: Boston Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Wearable pump trial aims to free hospital patients from IV stands
Knowledge-focused CompletedThis study tested special wearable pumps (elastomeric pumps) to give antibiotics through a drip to hospital patients. Nine adults with bacterial infections took part to see if the pumps are safe, easy to use, and could save time and money compared to traditional methods. The goal…
Sponsor: Stuart Bond • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New study sheds light on anemia in endocarditis patients
Knowledge-focused CompletedThis completed study looked at 209 patients with bacterial endocarditis, a serious heart valve infection, to understand how common anemia is and what causes it. Researchers measured blood markers for inflammation and anemia from diagnosis up to 6 months after hospital discharge. …
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New study tests smarter fluid delivery for septic shock patients
Knowledge-focused CompletedThis study looked at two ways to guide fluid treatment in 60 emergency department patients with septic shock: using ultrasound or a noninvasive heart monitor. Both methods aim to give the right amount of fluids to improve blood pressure and organ function. Researchers tracked sur…
Sponsor: Mai Xiaowei • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Pandemic measures linked to drop then surge in severe strep a in kids
Knowledge-focused CompletedThis study looked at how the COVID-19 pandemic and related measures like lockdowns and mask-wearing affected severe Group A Strep infections in children in Paris. Researchers reviewed medical records of 269 children under 18 admitted to a Paris hospital between 2018 and 2023. The…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:07 UTC
-
Listeria in newborns: does it cause lasting brain damage?
Knowledge-focused CompletedThis study looks at whether a listeria infection around the time of birth can lead to long-term thinking or behavior problems in children. Researchers will compare 53 children who had the infection with a control group using standard tests. The goal is to understand the role of t…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:38 UTC
-
Bismuth combo therapy for stomach bug under review
Knowledge-focused CompletedThis study looked back at medical records of 1,730 adults with H. pylori infection who received bismuth-containing quadruple therapy as their first treatment. Researchers compared how well different drug combinations worked and what side effects occurred. The goal was to identify…
Sponsor: Yueyue Li • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:22 UTC
-
Scientists probe immune cells in cystic fibrosis – no new drug, just knowledge
Knowledge-focused CompletedThis study looked at blood neutrophils (a type of immune cell) in 47 adults with cystic fibrosis. Researchers compared these cells between patients and healthy donors, and also examined how chronic infection, CFTR modulator drugs, and lung flare-ups affect neutrophil behavior. Th…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:33 UTC
-
Toxin tied to deadly staph pneumonia under the microscope
Knowledge-focused CompletedThis completed study looked at 234 patients with severe staph pneumonia to see if a toxin called PVL makes the disease worse. Researchers compared survival rates between patients infected with PVL-producing bacteria and those without. They also collected blood samples to explore …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:16 UTC
-
New study tracks how a common bacteria colonizes Babies' guts
Knowledge-focused CompletedThis completed study looked at how group B streptococcus (GBS) bacteria colonize the digestive tract of newborns. Researchers followed nearly 950 mothers and their babies, taking samples from the mother and umbilical cord at birth. The goal was to see if a specific, more dangerou…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:26 UTC